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1. INTRODUCTION 
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Since the mid-nineteenth century approximately, it’s began an unstoppable demographic 
revolution that in less than two centuries has led the life expectancy from about 40 to beyond 
the current 80 years, in other words a gain of about three months per year over the past 160 
years (Oeppen & Vaupel, 2002). This extraordinary lifespan increase is so widely spread to 
affect not only the most economically developed countries, but involves also other 
demographic giants as China and India and therefore should be considered a global 
phenomenon. 
 
According to the latest statistics projections formulated by Eurostat, the proportion of elderly 
EU-27’s population aged over 65 years old is predicted to increase from 17.5 % in 2011 to 
29.5 % by 2060 while the number of individuals aged 80 years and beyond is predicted to 
triplicate between 2011 and 2060 (Eurostat source, Capri et al. 2014).  
 
This "population explosion" makes extremely important to identify the factors (biological and 
non-biological) involved in aging devoid of major diseases and disabilities, identify the 
different genetic and molecular mechanisms which underpin the morbidity and mortality 
along with new strategies able to counteract or slow down its progress and in particular to 
decelerate the onset of age-related diseases and disabilities in order to increase the number of 
elderly people in good health. 
 
In this scenario the need of biomarkers of healthy or unhealthy ageing seems to be more and 
more necessary and urgent.  
 
The European Project MARK-AGE (European Study to Establish Biomarkers of Human 
Ageing) attempts to provide an answer to these needs that represent a strategic priority of the 
European Community in the context of health policies. The expected results will contribute to 
a greater understanding of the biological mechanisms of human ageing contributing to 
develop focused prevention strategies and to influence the diseases process and above all to 
improve their therapy. 
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1.1 HUMAN AGEING  
 
1.1.1 Demographic Ageing 
 
The aging of the population is currently one of the most significant worldwide demographic 
events (with substantial different timing and dynamics across countries), where it is producing 
the transformation of economic, social and cultural development and it will intensify during 
the twenty-first century. (Schoeni & Ofstedal 2010, United Nations 2013). In developing 
countries population ageing is a fairly new phenomenon but considering the rate of growth of 
their older population segment (significantly higher than in developed countries) it is 
reasonably expected that the older population of the world will increasingly be concentrated 
in the less developed regions. 
 
Which are the causes of this unprecedented phenomenon? Ageing is a dynamic process and 
many factors had contributed to the increase at global level of population aged 60+ and 80+ 
(Bloom et al. 2011): the decrease of mortality, the increasing life expectancy and fertility rates 
that in recent decades have reduced the relative number of young people and pushed up the 
share of the elderly. In support of this assertion there are data from World Population 
Prospects: the 2012 Revision (United Nations 2013), according to which the decline of 
fertility rate in most countries of the world in the last decades has been the main factor driving 
population ageing. 
 
According to Eurostat the consistently low birth rates and higher life expectancy will 
transform the shape of the EU-27’s age pyramid (Fig.1) and most likely the most significant 
change will be the marked transition towards a much older population structure and this 
development is already becoming apparent in several EU Member States (Eurostat 2012). 
 
The demographic aging of the population is a long-lasting process, because in the course of 
the twentieth century, the proportion of older people has continued to grow much faster than 
the growth of the total population. Within the elderly population, the age group that seems to 
grow more rapidly in the world is represented by people aged 80 years or more (Fig. 1). 
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Fig. 1Population pyramids, EU-27, 2010 and 2060 (% of the total population): 2010, provisional; 2060 
data are projections (EUROPOP2010 convergence scenario). Source: Eurostat 
 
In order to fully understand what implications this phenomenon may have it is important to 
take account of two significant demographic indexes: the ageing index and the old-age-
dependency ratio index. 
 
The ageing index represents a dynamic indicator that estimates the degree of population 
aging. The ageing index is a composite demographic ratio, defined as the percentage between 
the old age population (over 65) and the young population (under 15). It is one of the several 
demographic indicators that can be used to measure the rate at which a population ages. 
Values exceeding 100 indicate a greater presence of elderly subjects compared to young (Fig. 
2).  
 
 
 
 
 
 
 
 
Fig. 2 Ageing index in EU countries - Year 2010 (percentage values) Source: Eurostat 
 
According to World Population Ageing 1950-2050 (United Nations 2010), by 2050, the 
ageing index is predicted to range from a high of 263 per hundred in Europe against a low of 
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37 per hundred in Africa (Fig. 3). This means that by the end of the first half of this century, 
there will be almost three persons aged 60 or over for every child under 15 years in Europe, 
and almost three children under 15 years for every person aged 60 or over in Africa. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Ageing index projections 1950-2050 (Source United Nation 2010) 
The old-age dependency ratio demonstrates the proportion of the population aged 65+ relative 
to the working-age population. Dependency ratio is able to provide only an approximation of 
the dependency burden. In fact not all the elderly require support and on the contrary, there is 
evidence that older persons in many societies are providers of support to their adult children 
(Morgan, Schuster and Butler, 1991; Saad, 2001). As for ageing index, the old-age 
dependency ratio projections for 2050 are less than encouraging (Fig. 4):  
 
 
 
 
 
 
 
 
 
 
Fig. 4 Old-age dependency ratio projections 1950-2050 (Source United Nation 2010) 
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United Nations estimates that the old-age dependency ratio will almost double in Northern 
America, Africa and Oceania; it will more than double in Europe; and more than triple in Asia 
and in Latin America and the Caribbean (Fig. 4) 
 
Due to the fact that old-age dependency ratio is considered to be a coarse index it has been 
proposed to decompose it into two additive indicators: the old- age unhealthy dependency 
ratio and the old-age healthy dependency ratio. The new indicators distinguish between a) 
the burden of those who are in good health and could potentially remain in the labour force; 
and b) those who are disabled or have chronic conditions and are more likely to require 
financial and health care support (Muszyńska & Rau 2012). 
 
With this premises a real emergency, related to the strong growth of the great elders who in 
all likelihood be accompanied by a dramatic decline of people with less than 80 years, can be 
expected. Another important feature of the demographic trend is the greater number of older 
women than men that make up over 70% of the individuals aged over 80 years. All these 
factors are crucial in terms of health and social care, because octogenarians women represent 
the portion of the population with the greatest care needs, given the high degree of co-
morbidity and disability that characterizes them (Gollini 2005). 
 
1.1.2 Social and medical consequences of ageing  
 
Aging population is a phenomenon that affects the entire world and that may have important 
implications in the fields of social and health services. Aging does not involve only the 
elderly but also families, as it grows the number of coexisting generations, and the general 
population since we have an increase in the proportion of elderly and old people in the total 
population along with a contraption of births. 
 
While the strong demographic aging is the manifestation of significant medical, social, and 
economic advances over disease that is able to lengthen the life expectancy, on the other hand 
it also presents tremendous challenges since it leads to a greater number of age-related 
diseases and bring out the question of long term assistance.  
 
The response to this population needs is measured through home care and specialized 
institutions. This is therefore an issue that can become difficult to sustain by the society, if not 
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accompanied by appropriate interventions. It must be remembered that age brings double the 
risk of comorbidity and disability, and the fragility of the elderly is characterized by this 
double jeopardy and the psycho-social failure that comes with it. One of the important points 
in the analysis of an aging population it is the disability and loss of functional autonomy, 
which unfortunately often characterized the last years life. 
 
This rapid aging of the population is associated with major changes in the structure and roles 
of family such as the vertical of the extended family, the rise of single-person households and 
single women and widows. This consequently leads to the necessity of help for those who 
have lost autonomy in daily life along with problems of intergenerational solidarity (also due 
to the different social roles of women, traditional lenders of care) and long term care. The lack 
of social and family relationships that more and more frequently characterize the elderly are 
causal factors of mortality and morbidity (Keller et al., 2003). Generally, loneliness in the 
elderly becomes a cause of suffering and psycho-physic regression. The older couples tend to 
isolate sometimes more than single subjects. Finding new strategies that can allow to better 
address this new "trend" demographic it’s extremely necessary. From the Assembly of 
Madrid, the World Health Organization has implemented a series of policies and programs 
that aim to promote what has been named "Active Aging", which has as its objectives the 
autonomy, the independence, quality of life of the individual, taking into account that mental 
health and social relationships are critical to the improvement of the physical state. 
 
European Union took note of the necessity to reform and adapt social protection systems, 
including health care, to cope with an aging population and identified three key point: 
 
1. Accessibility of care which must take into account the needs and difficulties of the 
most disadvantaged groups and individuals, but also to those who need costly long-
term care; 
 
2. Offering quality care that keeps pace with scientific research and that adapts to the 
needs associated with the aging process and based on an evaluation of health benefits; 
 
3. Long-term financial sustainability of care and a more efficient system. 
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1.1.3 Ageing mechanisms 
 
Aging is a complex process not entirely understood. Aging is a process that affects most of 
living organisms. In humans from the moment of conception until death occur a series of 
changes in processes and physiological parameters, with the acquisition of new skills and loss 
or maintenance of others, which determines the resulting aging of the whole organism. During 
the last decades many theories were formulated, one of the most recent is that proposed by 
MV Blagosklonny (Blagosklonny 2013), named “quasi-programmed", where aging is a 
wasteful and aimless continuation of developmental growth, driven by nutrient-sensing, 
growth-promoting signaling pathways such as MTOR (mechanistic target of rapamycin) (Fig. 
5, 6 and 7).  
Fig. 5 Ageing theories comparison (Blagosklonny 2013) 
 
 
 
 
 
 
 
Fig. 6 From cellular growth to hypertrophic senescence (gerocon-version) (Blagosklonny 2013). 
Fig. 7 From developmental growth (program) to aging (shadow) (Blagosklonny 2013). 
 
Ageing is well known to be characterized by considerable heterogeneity due to the complex 
interactions between genetics and epigenetics, affecting the rate of ageing in humans (Capri et 
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al., 2006; 2013), environmental conditions (Biagi et al., 2013; Garm et al., 2013) and 
stochasticity. 
 
Aging has been described as a complex mosaic, resulting from the interaction of a variety of 
environmental, stochastic and genetic-epigenetic events/stimuli and affecting differently all 
levels of biological organization (macromolecules, organelles, organs etc.). (Cevenini et al., 
2008) (Fig. 8) According to this mosaic depiction, tissues and organs might age at different 
rate and further, individuals of same chronological age might have different biological age 
(Capri et al., 2014). The presence of this complexity surely makes more difficult the 
identification of a unique comprehensive mechanism of ageing and related biomarkers (Capri 
et al., 2014, Deelen et al., 2013).  
 
 
 
 
 
 
 
 
 
 
Fig. 8 Representation of ageing mosaic in which every organ (represented in different colour) is differently 
affected in various degree. The frame (in various colours) indicates the effect of genetics, environment and 
stocasticity (Cevenini et al. 2008) 
 
The phenotype of the aged individuals is very complex because is the result of the continuous 
remodelling ability of the body (Franceschi et al., 2000; Spazzafumo et al., 2011) to adapt to 
the unrepaired damages which can occur to the level of macromolecules, cell, and organs. 
According to the remodelling theory of aging (Franceschi et al. 1995, 2000;) the ageing 
phenotype is the result of two major process:  
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• accumulation of unrepaired damages at all levels of the biological organization (molecules, 
cells, tissues, organs) 
 
• capability of the body to react/adapt/neutralize such damages by activating a variety of 
physiological molecular and cellular repair and defence responses/pathways 
 
The remodeling that occurs in the human body is based on and performed by fundamental 
biological responses, such as DNA repair, apoptosis, immune response and inflammation 
”(Franceschi 1995, 2000). This process can take different pathways during the different 
phases of life. In fact it represents an extremely positive factor, in terms of survival, during 
the reproductive phase of life but it may be detrimental in the post-reproductive period of life 
since this was unpredicted by evolution (antagonistic pleiotropy) (Franceschi 2000). So a 
successful remodeling can lead to longevity while on the contrary an unsuccessful remodeling 
can take the body to disease and death. 
 
One of the key point of aging process is inflammation in fact ageing is accompanied by a low 
grade of chronic inflammatory status derived from an imbalance between inflammatory and 
anti-inflammatory networks (Franceschi et al. 2000, 2007) (fig. 9). This phenomenon was 
denominate “Inflammaging (Franceschi et al. 2000, 2007, Cevenini et al., 2013). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 The balancing between pro- and anti-inﬂammatory agents. Efﬁcient inﬂammatory responses can 
confer high resistance to infectious diseases, but also an increased susceptibility to inﬂammation-based 
diseases later in life. On the other side, low inﬂammatory responses, while rendering more susceptible to 
infectious diseases, can confer a survival advantage in old age. (Franceschi et al., 2007) 
15 
“Inflammaging" is determined by the antigenic load that acts on the body throughout life and 
it is based on the assumption that the immune response and the targeted one against stress are 
equivalent and that the antigens should be regarded as a particular category of stressors. 
(Franceschi et al., 2000) 
 
Inflammaging plays a crucial role in human health and ageing since the majority of age-
related diseases such as metabolic syndrome, cardiovascular diseases, hypertension, type 2 
diabetes, Alzheimer etc. share an inflammatory pathogenesis (Santoro et al., 2013). Moreover 
several geriatric conditions such as osteoporosis (Lencel and Magne, 2011), sarcopenia 
(Pedersen et al., 2009), or frailty (De Martinis et al., 2006) are highly influenced by 
inflammation. 
 
Inflammation is not only a local, tissue restricted event but could also be a systemic process 
involving a variety of tissues (adipose tissue, muscle), organs (brain, liver), systems (immune 
system) and ecosystems (gut microbiota) of the body (Cevenini et al., 2010; Cevenini et al., 
2013, Santoro et al., 2013) being a crucial component of immunosenescence. 
 
In recent years is emerging more and more the role of N-glycomic profile in the blood and its 
age related changes associated with inflammaging as it will be described. 
 
A N-glycan (N-linked oligosaccharide) is a sugar chain covalently linked to an sparagine 
residue of a polypeptide chain. The linkage commonly involves a GlcNAc residue and the 
consensus peptide sequence Asn-X-Ser/Thr. Glycans are involved in a wide range of 
biological processes due of their mass, shape, charge and other physical properties. Glycan 
chain structures are not encoded directly in the genome but are secondary gene products 
unlike protein sequences (Vanhooren et al., 2010) 
 
On the basis of which mechanisms N-glycans are linked to inflammation? The alteration of 
glycosylation reactions can lead to agalactosylated N-glycans formation of decorating 
immunoglobulins G (IgG) and other glycoproteins (Vanhooren et al., 2010; Santoro et al., 
2013). These IgGs are also called IgG-G0 and seem to be associated to several pathological 
conditions such as rheumatoid arthritis and other autoimmune diseases along with cancer, in 
which inflammation has a leading role (Dall’Olio et al., 2013, Santoro et al., 2013). 
According to Dall’Olio et al., proposed model of correlation between IgG-G0 and 
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pathogenesis of inﬂammatory conditions and aging (Fig.10) it is thought that the systemic 
inﬂammatory condition may alters the glycosylation machinery of antibody-producing cells, 
leading to increased expression of agalactosylated and poorly sialylated IgG. The abnormally 
glycosylated IgG activate different effector branches of the immune system causing the 
ampliﬁcation of inﬂammatory signals. 
 
The mechanism underpinning IgG-G0 and inflammation link is not clear. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10 Proposed model of IgG-G0 in the pathogenesis of inﬂammatory conditions and aging (Dall’Olio et 
al., 2013).  
 
 
1.2 MARK-AGE PROJECT 
 
1.2.1 MARK-AGE Project background 
 
Many evidences indicate that the rate of ageing differs significantly between members of the 
same animal species, including humans. In other words, the “biological age” may differ from 
the “chronological age”. The "demographic explosion" of which we are witnesses requires 
urgent solutions. It is in this perspective that ageing biomarkers fit. But what does is mean 
with the term “ageing biomarker”? An ageing biomarker essentially is an age-related 
change(s) in body function or composition that could be used as measure of “biological” age 
and the ageing rate. 
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The purposes for which these biomarkers could be used are very numerous: 
 
1. Early detection of subject at high risk of developing age –related pathologies 
 
2. Assessment of the efficacy of pharmacological, dietary or physical interventions. 
 
The European Project MARK-AGE is not the first study that deals with this subject and 
during the years several exponent of scientific world tried to identify, without success, useful 
biomarker able to determine the “biological age”. The reasons behind these failures are 
attributable to: 
 
1. No Europe-wide study has been conducted so far so weak statistical power. 
 
2. Old or very old probands were recruited and this made difficult to differentiate 
between real biomarkers of ageing from biomarkers of incipient or overt disease. 
Furthermore using exclusively cohorts of old volunteers the obtained data weren’t 
informative for middle aged subject  
 
3.  Studies focused on single candidate biomarkers etc. 
 
1.2.3 MARK-AGE Consortium 
 
The MARK-AGE consortium consists of 26 Beneficiaries coming from 14 European 
countries (Austria, Belgium, Danmark, Finland, France, Germany, Greece, Italy, 
Netherland, Poland, Romania, Spain, Switzerland e Great Britain), comprising 21 non-
profit organizations (universities and public research  institutes), 3 small and medium  
sized enterprises (SMEs), and 2 large companies (Table 1). The project is coordinated by 
Prof Alexander Bürkle, University of Konstanz, Germany. The Scientific and Project manager 
is Dr. Maria Moreno Villanueva, University of Konstanz, Germany.  
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Table 1 MARK-AGE Beneficiaries 
 
1.2.3 MARK-AGE strategy and major goals 
 
The major goals of the MARK-AGE Project are the following: 
 
1. To perform a comprehensive Europe-wide population-based study enrolling about 
3,700 volunteers aged 35-74 years and representative of several different European 
geographical region with the purpose of identify human ageing biomarker. 
 
2. To recruit three large groups of subjects from different  European countries 
19 
a. 2320 Randomly recruited Age-Stratified Individuals from the General 
population (RASIG) age range 35-74 years, belonging to both sexes Equal  
numbers of men and women will be enrolled, comprising in the following age 
classes: 35-39 yrs, 40-44 yrs, 45-49 yrs, 50-54 yrs, 55-59 yrs, 60-64 yrs, 65-69 
yrs, 70-74 yrs. The volunteers are recruited as representative of the “normal” 
or physiological aging. 
b. 700 Offspring of long-living parent belonging to a family with long living 
sibling(s) already recruited in the framework of the GEHA project (“GEHA 
offspring” or simply GO) recruited together with their spouses as controls 
(“GEHA Offspring Spouse” or simply SGO) aged 55-74 years. These subjects 
are recruited as representative of “successful” or decelerate aging. 
c. A small number of patients with Progeroid Syndromes (Cockayne, Werner 
and Down Syndromes), characterised by accelerated “segmental” ageing. 
 
3. To extract a robust set of biomarkers of human ageing and to derive a model for 
healthy ageing and also able to predict “bioage”. 
 
4. To follow up a limited random sample of probands in a small longitudinal study, 
compatible with the time constraint of the project (5 years) by re-sampling 12% of the 
recruited subjects (RASIG, GO, SGO) (about 450 subjects) and 50% of DS after 4 
years. 
5. To collect anthropometric, demographic, clinical and social data on probands and 
to obtain fasting samples of blood, buccal mucosal cells and urine. 
 
 
 
 
 
 
 
 
 
 
Fig. 11 MARK-AGE overall strategy of the work plan 
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The candidate biomarkers included in the analysis are (Table 2): 
 
1. “classical” ones validated by several smaller studies  
2. “new/specialised” ones, based on preliminary data obtained in small-scale studies 
3. “novel” ones, based on recent research on mechanistic aspects of ageing, conducted 
by project beneficiaries. 
Table 2. MARK-AGE Candidate biomarkers 
 
Classical physiological parameters 
 Body mass index  
 Waist  and hip circumference 
 Blood pressure at rest  
 Heart rate at rest 
 Lung capacity- FEV1 
 Lung capacity- FVC (forced expiratory vital capacity) 
 Near vision 
 Physiological postural equilibrium (maintenance of standing, tandem and semi-tandem position) 
 Five -times chair standing 
 Handgrip strength 
  
Clinical chemistry analyses: 
 Blood urea nitrogen and creatinine 
 Fasting glucose and fasting insulin 
 Glycosylated hemoglobin (A1C) 
 Albumin and serum protein concentration 
 Fasting triglycerides and free fatty acids 
 Total cholesterol, HDL and LDL-cholesterol 
 Noradrenalin, serotonin and 17-hydroxycorticosteroid 
 C-reactive protein (CRP) and fibrinogen 
 Serum amyloid A and P, and pentraxin 3 
 Adiponectin 
 Testosterone (will be measured in males only) 
 Prostate specific antigen (PSA) 
  
Specialised tests established by Partners 
 Cellular poly(ADP-ribosyl)ation capacity and DNA repair in PBMC 
 DNA methylation status in PBMC 
 Telomere length in PBMC 
 Changes in mitochondrial DNA in blood cells 
 APOE genotype 
 Vitamin levels in mucosal cells 
 Zn, Cu, Se and  Fe in plasma and PBMC; metallothionein expression 
 Oxidative stress markers 
 Glycation 
 Serum glycans 
 Cytokines 
 ApoJ/clusterin 
 Proteasome, methionine sulfoxide reductases 
 Immunity against specific pathogens 
 Autoantibodies 
 Damage-Induced Cell Death and Activation-induced cell death in lymphocytes 
 Thymic output 
 Serum lipids including LDL particle size 
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Since not all biomarkers are of equal weight only the best ones were matched and used for 
measuring the biological age. 
 
1.2.4 Training 
 
The scientific success of this Large-Scale Integrating Project, comprising 26 Beneficiaries, 
depends  on  the  internal  data coherence,  integration  of  the  work  to  be  performed  by  
each  participant.  Training activities have been based mainly on two main programmes:  
 
(1) Training through research 
 
(2) Specialized courses at summer schools.  
 
During the first and the fourth project year, one-week summer schools for postdocs and PhD  
students involved in the project have been held.   
 
The first summer school was held jointly with the FP6 Concerted Action LINKAGE on 29 
June - 03 July 2009 in Fréjus, France. The topics covered in this summer school was the 
following: model systems in research on ageing, molecular mechanisms of ageing, in vitro 
systems, ROS and ageing, DNA damage and repair, cancer and ageing, methodology for gene  
expression analysis.  
 
The second summer school was held jointly with the conference series Neurobiology and 
Neuroendocrinology of Aging, on 29 July - 02 August 2012, Bregenz, Austria.  
 
Training was also implemented by exchange of researchers, especially young researchers, 
between Consortium members, with an emphasis on the technology platforms. Within the 
consortium there are excellent opportunities for training in specialised techniques. 
Novel biomarkers yet to be established 
 Serum and PBMC proteomics 
 Metabonomics 
 Gene  expression  and  protein  profiling  of  blood  cells  (B  cells,  T  cells)  exposed  to 
physiological oxygen tension 
 Proteins secreted by endothelial cells and fibroblasts 
 Biomarkers of ageing in the mouse and in Cockayne’s syndrome patients 
 microRNAs 
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A dedicated training was organized with all the recruiting Beneficiaries for the teams 
involved in the recruitment, data collection and data entry. A thorough explanation and a 
practical demonstration of all the items included in the informed consent and case-sheet has 
been performed in order to standardize the procedures and minimizing the risk of operator 
errors. 
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2. AIM OF THE STUDY 
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This dissertation is part of the Integrated European Project “MARK-AGE – European Study 
to Establish Biomarkers of Human Ageing” (Seventh Framework Programme Theme Health-
2007-2.2.2-3 Biomarkers of Ageing), whose aim is to identify a robust set of biomarkers of 
human ageing able to discriminate between chronological and biological ageing and to derive 
a model for healthy ageing and also able to predict “bioage”. 
 
The specific aims of this thesis are the following: 
 
1. To illustrate the recruitment of three selected groups of subjects from different 
European countries 
 
a. Randomly recruited Age-Stratified Individuals from the General population 
(RASIG) age range 35-74 years, belonging to both sexes The volunteers are 
recruited as representative of the “normal” or physiological aging. 
b. Offspring of long-living parent belonging to a family with long living 
sibling(s) already recruited in the framework of the GEHA project (“GEHA 
offspring” or simply GO) recruited together with their spouses as controls aged 
55-74 years. These subjects are recruited as representative of “successful” or 
decelerate aging. 
c. A small number of patients with Progeroid Syndromes (Cockayne, Werner 
and Down Syndromes), characterised by accelerated “segmental” ageing. 
 
The recruitment of Progeroid Syndrome patients will be only briefly mentioned since 
these individuals won’t be considered for the analysis performed in this dissertation.  
 
2. To perform an accurate analysis of the health status of elderly recruited GO-SGO 
and RASIG volunteers aged 60-79 years, verifying any possible dissimilarity in their 
aging trajectories. 
 
3. To identify a set of robust ageing biomarkers. 
 
4. To investigate possible correlations between ageing biomarkers and health status 
of recruited volunteer. 
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3. MATERIALS AND METHODS 
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3.1 PRELIMINARY ACTIVITIES TO THE RECRUITMENT 
 
3.1.1 Selection of the Study Population  
 
Three populations were recruited as follows (Capri et al. 2014): 
 
1. Subjects representing the “Normal” or “Physiological” aging: Randomly recruited 
Age-Stratified Individuals from the General population or RASIG, covering the age 
range 35-74 years (both sexes). 
 
2. Subjects representing the “successful” or “decelerate” aging: subjects belonging to 
long living families, enriched of pro-longevity characteristics. Offspring of long 
living siblings previously recruited in the framework of the GEHA “Genetic of 
Healthy Ageing” project (Skytthe et al., 2011). GEHA offspring” or GO were 
recruited together with their spouses (SGO) as best control to evaluate possible life 
style effects, since they shared the same environmental factors for many years with 
their partners. Age range: 55-74 years (both sexes). 
 
3. Subjects representing “accelerated” aging: patients affected by progeroid 
syndromes (Cockayne, Werner and Down syndromes), characterised by accelerated 
“segmental” ageing.  
 
Each recruitment unit focused their activity on different populations: 
 
RASIG population: BioTeSys GmbH (Germany), University of Namur (FUNDP, Belgium), 
Österreichische Akademie der Wissenschaften (OEAW , Austria), Institute of Experimental 
Biology (NENCKI, Poland), National Hellenic Research Foundation centre (NHRF, Greece), 
University of Tampere (UTA, Finland) and University of Bologna ALMA MATER 
STUDIORUM (UNIBO, Italy). 
GO/SGO population: University of Leiden (LUMC, Netherland), University of Tampere 
(UTA, Finland), NENCKI, UNIBO, FUNDP and NHRF.  
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Down Syndrome population: University of Bologna ALMA MATER STUDIORUM 
(UNIBO, Italy). 
 
Cockayne and Werner Syndrome DNage B.V. (Netherland) and University of Konstanz 
(UKON, Germany) were in charge for the collection of existing blood samples from patients 
recruited by external collaborators  
 
3.1.2 Inclusion and exclusion criteria 
 
Inclusion criteria 
 
1. RASIG: Randomly recruited age-stratified individuals from the general population 
(both sexes) aged 35-74 years, able to give informed consent and living in country of 
residence for longer than 50% of lifetime. 
 
2. GO and SGO: Offspring (sons or daughters) of GEHA siblings and GO spouses 
(SGO) aged 55-74 years and able to give informed consent.  
 
Exclusion Criteria 
 
1. Self-reported seropositivity for HIV, HBV (except seropositivity by vaccination) 
and HCV (HBV and HCV seropositivity was assessed after blood collection). 
2. Presence of cancer and current use of anti-cancer drugs or glucocorticoids. 
3. Less than 50% of lifetime spent in country of residence.  
4. Inability to give informed consent 
 
3.1.3 Standardization of Recruitment Tools 
 
All the beneficiaries involved in the recruitment had to prepare a set of standardized 
documents that includes: 
 
a) A standardized invitation letter that was sent to all the eligible volunteers (RASIG, 
GO and SGO) as first approach. 
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b) An Informative Sheet containing exhaustive information, written in a clear and 
understandable way, with the purpose of explaining, the background, goals and the 
study procedures (interview, physical examination and sampling of blood, urine, 
buccal mucosa cells and saliva). 
c) A Synopsis summarizing the focal points of the project. 
d) An Informed Consent form redacted in compliance with the local legislation in the 
different European countries involved in the recruitment. 
e) Four Questionnaires, that have to be uniformly used for all the recruited subjects  
 
3.1.4 Phenotipic questionnaires design 
 
Four standardized questionnaires were produced using part of the questions which were 
consolidated in previous European studies on elderly subjects and younger controls (such as 
GEHA).  
 
Interview Questionnaire Part I-A (to be filled out by all study participants at home) 
containing questions regarding: 
 
1. Basic biographic information: family composition, parents’ causes of death, marital 
status, education level, main occupation (classified according to ISCO classification), 
living condition and social network. 
2. Life style: smoke, food habits and alcohol intake. 
3. Basic Health Information: SF-36v1 Health Survey, present and past pathologies, use 
of prescribed medicines, falls, hospitalization and change of weight in the last 12 
month, vaccination against tetanus and HBV, use of hormonal contraceptives or 
hormone replacement therapy in the last year (females only), presence of presbyopia. 
 
Interview Questionnaire Part I-B (to be filled out only by over 60 years participants at 
home) including: 
 
1. Katz’s ADL (Activity of Daily Living) (Katz et al., 1970). 
2. Questions from the Nagi-scheme (Nagi SZ, 1976) regarding ability of reading 
newspaper without glasses or other aids, clearly recognize someone 4 metres away 
without glasses, hearing ability without aids, half a kilometer/a quarter of a mile 
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walking without aids, going up and down a flight of stairs without anyone’s help, 
doing any kind of light housework or exercise, going outside with or without anyone’s 
help.)  
 
Interview Questionnaire Part II-A (to be filled out by the interviewer) consisting in: 
1. Blood pressure measurements (at the beginning of the interview and after the 
cognitive assessment) 
2. Cognitive and mood evaluation: 
a. 15 Picture Learning Test (15-PLT): it assessed the immediate and delayed 
memory function. 15 pictures of well-known items were shown to the 
participants and then asked to recall as many as possible. The test consists in 
three consecutive and repeated trials and a postponed recall after 20 minutes. 
The total number of correct answers after three trials was defined as the 
immediate recall while the number of correct answers after 20 minutes as 
delayed recall. Outcome parameters were the number of correct pictures 
remembered immediately and after the pause. The number of incorrect pictures 
for each trial was reported. A low score indicates worse cognitive 
performance. (Brand and Jolles, 1985). 
b. Stroop-Colour-Word-Test: it was used to test selective attention. The test 
consists in three sheets showing 40 stimuli each, which the subject was asked 
to read or name as quickly as possible: (1) colour names, (2) coloured patches, 
and (3) colour names printed in incongruously coloured ink. Difficulty of part 
3 is mostly due to the need to discard irrelevant information (verbal), in favour 
of a less obvious aspect (colour naming). This phenomenon is also known as 
cognitive interference. The main outcome was the times needed for each of the 
three trials and a higher score denotes a worse performance (Stroop, 1935). 
c. Digit-Symbol Substitution Task (DSST) is a psychometric test and it was 
used to evaluate processing speed and sustained attention. In this test digits 
were presented and the participants were asked to write down the 
corresponding symbols in a blank space according to a provided key. Outcome 
parameter was the number of correct written symbols within 90 seconds. A 
low score denotes worse cognitive performance (Lezak et al., 2004). 
d. Zung Self-Rating Depression Scale is a short (20 items) self-administered 
scale able to assess the level of depression in patients diagnosed with 
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depressive disorder. It is widely used as a screening tool, covering affective, 
psychological and somatic symptoms associated with depression. It is 
composed by ten positively worded and ten negatively worded questions. Each 
question is scored on a scale of 1 through 4. A higher score indicates a more 
depressed status (Zung, 1965). 
 
Interview Questionnaire Part II-B (to be filled out by the interviewer only with over 60 
years participants) consists in:  
 
 Mini-Mental State Examination – SMMSE (Molloy et al., 1991) is the most 
commonly used instrument for screening cognitive function. The test is not suitable 
for making a diagnosis but can be used to indicate the presence of cognitive 
impairment. 
 
3.1.5 Local Ethics Committee authorization 
 
One of the main goals during the first year of the project was to obtain the approval of the 
local ethical committees. For this reason a standardized version of the necessary documents 
(invitation letter, informative sheet, informed consent, questionnaires etc.) was prepared. Due 
to different ethical requirements between countries, it was necessary to make appropriate 
adjustments in order to be compliant with the different legislations. All the documents were 
then translated into the national language and submitted to local Ethical Committee for 
approval. 
 
3.1.6 The TRY-Phase 
 
In order to evaluate that all procedures were applied in the correct way and to monitor the 
'"time effect" between the sample collection and the beginning of the processing, a test phase 
called “TRY-Phase” was performed. The entire standard operating procedure, from 
recruitment (informed consent, questionnaires), sample collections and processing, subject 
coding to entry data and analytical measurements was simulated. For this purpose, a group of 
volunteers who were excluded from the MARK-AGE study were selected. 
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3.2 RECRUITMENT STRATEGIES OVERVIEW 
 
 
3.2.1. Recruiting Units different approaches 
  
In population-based studies the set-up of volunteers’ recruitment strategy is a very crucial 
phase perhaps the most challenging part of a clinical research on which depend the success of 
the experimentation since problems with recruitment can disrupt the timetable for a research 
project (Patel et al. 2003).  
 
The difficulty of this process is further increased when recruitment needs to be planned in 
different nations as it has to take account of geographical, social and cultural differences 
between the countries involved. For this reasons it was decided that each recruiting unit 
would pursue different approaches, in order to reach the largest number of potential 
volunteers. Consequently specific and country oriented strategies were applied according to 
the population to recruit (GO, SGO or RASIG volunteers). 
 
Every unit previously involved in GEHA Project recruitment was able to take advantage of 
past references in order to directly locate possible candidates or at least tried to reconnect with 
families in order to reconstruct the network of contacts useful for recruitment.  
 
Though each partner adopted different strategies the use of mass media was chosen as 
preferential way of communication and dissemination. In fact the involvement of newspapers, 
radios and local TVs along with production of advertising material (flyers, posters etc.) 
played a decisive role in the success of MARK-AGE recruitment.  
 
In the table below are summarized the main strategies adopted by each recruitment centres 
(Table. 3) 
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Beneficiary  Population Dissemination and Strategy of recruitment  
BioTeSys GmbH 
(GERMANY) 
RASIG Newspaper articles, information evening at the town hall together with the 
governing mayor; registration office (letter /flyer), volunteers known from 
other trials conducted at BioTeSys, a little word-of-mouth recommendation. 
FUNDP/ 
StratiCELL 
(BELGIUM) 
RASIG/GO/SGO Contacted an open-university for persons belonging to the 3rd age and all 
societal horizons; the Services of the Human Resources of the City of Namur, 
the Univ. of Namur, Univ. Clinics of Mont-Godinne, and Regional Hospital 
Centre, dealing with all sorts of personnel; organised press conference at 
Univ. of Namur (many press articles, interviews on national radios, local TV 
news, national TV programme on ageing). GEHA references for GO list 
LUMC 
(NETHERLANDS) 
GO/SGO Drafted a list with a number of picked nominatives (GEHA  references) . 
NHRF 
(GREECE) 
RASIG/GO/SGO Contact by email all the personnel of Research Institutes of Athens. 
Contact by phone call all the GEHA siblings giving information to GO/SGO 
on MARK-AGE, sending them the informative sheet by post or fax.  
Contact by phone call all our personal acquaintances giving information on 
MARK-AGE.  
NENCKI 
(POLAND) 
RASIG/GO/SGO Obtained addresses of 3200 RASIG from Ministry of Interior and 
Administration according to PESEL (National Electronic Census Number 
System); sent 240 letters of invitation , 22% responders feedback by phone or 
e-mail  GEHA  references for GO list 
UIBK 
(AUSTRIA) 
RASIG Articles in a very common Tyrolean daily newspaper; dissemination on local 
TV news and articles in other newspapers and magazines. 
UNIBO 
(ITALY) 
RASIG/GO/SGO/
DS 
GO and SGO were recruited before RASIG: drafted a list with a number of 
picked nominatives GEHA references for GO list. RASIG: population of 
PIANORO (a small city of about 17,000 inhabitants near Bologna); contacts 
with the Mayor and the District of Public Health. The project was illustrated 
to the Pianoro population including the local general practitioners; and 
disseminated to the local newspaper and TV. Flyers were also prepared and 
distributed in the local supermarkets. Another group of volunteers was 
recruited by an advertisement on the website of the University of Bologna. DS 
and their family were contacted by specific associations in Bologna 
UTA 
(FINLAND) 
RASIG/GO/SGO Newspapers, local TV announcements. GEHA  references for GO list 
Table 3 Mark-Age different recruitment strategies among the beneficiaries (Capri et al. 2014) 
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3.2.2 The UNIBO experience 
 
The UNIBO experience was quite peculiar since it was in charge of recruitment of GO, SGO, 
RASIG volunteers’ along with subjects affected by Down Syndrome and this required the 
development of accurate and targeted approaches.  
 
In UNIBO, MARK-AGE recruitment started with the identification of possible eligible GO 
and SGO candidates. This research was carried out using a list with a number of picked 
nominatives drafted during GEHA recruitment. In order to optimize the search of participants, 
avoiding energy dispersal and waste of valuable time, an ad hoc recruitment procedure was 
developed by recruiters (Fig. 12).  
 
Fig. 12 GO-SGO recruitment procedure 
 
Every possible candidate was firstly contacted by phone, sometimes using their old GEHA 
parents as intermediaries. If the subject refused to participate, information about the presence 
of cousins that could be available were asked otherwise in case of acceptance the prepared 
invitation letter and the informative note were sent by regular mail or email. After some days 
the possible candidate were contacted again by phone. If the response was positive an 
appointment was scheduled otherwise the search started again. 
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RASIG recruitment was mainly carried out in Pianoro, a little town near Bologna and 
partially between Bologna University employees. In order to obtain a successful recruitment 
of RASIG subjects in Pianoro the elaboration of communication strategies was necessary. The 
involvement of University of Bologna, Mayor and City Council of Pianoro, Public Health 
District, General Practitioners (GPs), voluntary associations was indispensable to establish 
medical-scientific synergies and to set-up a connections network where citizens could find 
information on MARK-AGE project. The dissemination was accelerated with the creation of 
informative material (flyers and posters) left near institutional centers and aggregation places 
such as City Council, local Health Centre, General Practitioners ambulatories, pharmacies, 
supermarkets etc. 
 
The recruitment between University of Bologna employees or their relatives was promoted 
and facilitated by an advertisement on the official University website. 
 
Also with RASIG volunteers an ad hoc procedure was developed (Fig. 13) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13 RASIG recruitment procedure 
 
UNIBO team was the unique centre in charge of recruitment Down Syndrome patients and 
this required the development of accurate and targeted approach. The subjects affected by 
Down Syndrome and their family were contacted by specific associations in Bologna. 
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3.3 QUESTIONNAIRES ADMINISTRATION AND SAMPLES 
COLLECTION PROCEDURES 
 
The questionnaires administration and samples collection was preferably performed at 
University of Bologna whenever was possible or at volunteer’s home. Before collecting any 
kind of information, the informed consent was firstly explained in every detail to the 
participant and then signed by candidate and by the recruiter (a MD or a nurse or specifically 
trained biologist). From every participant were collected 50 ml of blood by phlebotomy, after 
overnight fasting (water and medications excluded), urine (at least 19 ml) and buccal mucosa 
cells. From the total amount of blood collected, 2.7 ml of whole blood was sent to the local 
clinical chemistry laboratory for blood counts. After the blood withdrawal and breakfast the 
questionnaires were administered and questionnaires completed at home were thoroughly 
checked.  
 
3.4 BIOLOGICAL SAMPLES PROTOCOL 
 
3.4.1. Coding protocol  
 
All the collected data, personal information contained in the questionnaires or obtained from 
biological samples are sensible data and as such they require confidentiality that has to be 
ensured by complying with the legislation. All the samples and the questionnaires were coded 
at each recruitment centre by assigning to each volunteer a unique number consisting in 7 
digits based on coding scheme (the first two numbers defining the MARK-AGE recruiter 
centre followed by a five digit number), called PrimaryID (PID). The code was held 
exclusively at the recruitment centre in compliance with national legislation. All data obtained 
from the laboratory analysis were entered into the bio-bank and the central database only 
using a secondary code (PID2) generated and held by Beneficiary 1 only and not released to 
anybody. Only PID2-coded biological samples were exchanged between Beneficiaries for ad 
hoc analysis.  
 
3.4.2. Sample processing protocol 
 
In order to standardize the sample collection all the recruitment centres were supplied with 
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pre-labelled material directly by the Biobank (Moreno-Villanueva et al. 2014).  
 
1. 8 blood monovettes (ranging from 2.7 to 9 ml) containing lithium heparin, EDTA or 
clotting activator. 
 
2. 29 cryo tubes (ranging from 0.5 to 15ml)  
 
3. 1 kit devoted to buccal mucosa cells collection and consisting of a special toothbrush, 
a stabilizer solution and empty tubes.  
 
Awaiting the processing: 
 
 The monovettes were stored at room temperature in the dark (before starting of the 
preparation protocol). 
 Urine was stored at 4°C or on ice before freezing 
 Buccal Mucosa Cells suspension was stored at 4°C or ice cooling, in the dark for no 
longer than 10 hours before freezing 
 
The processing protocol was performed as follows:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For each volunteer the time necessary to complete the whole procedure was about 2-2.5 
hours. 
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3.4.3. The Biobank 
 
The MARK-AGE Biobank represented a focal point of all project since its activity was 
fundamental for several aspect of MARK-AGE processes. It was located at the University of 
Hohenheim, Germany and precisely at the Institute of Biological Chemistry and Nutrition. 
The main purpose of MARK-AGE Biobank was to provide standardized equipment for 
samples collection to all the recruitment centres, to manage samples incoming and outcoming 
(from the recruitment centers and to the analytic partners), sample re-labelling and splitting 
and storage along with sample tracking (Moreno-Villanueva et al. 2014).  
 
 
Fig. 14 Role of Mark-AGE Biobank 
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3.5 MARK-AGE DATABASE 
 
All the information collected with questionnaires, anthropometric data along with biological 
data obtained by blood, urine and buccal mucosa cells belonging to each MARK-AGE 
volunteer were stored electronically in the MARK-AGE database (Fig. 15). All the data were 
put in through a secure internet link. 
 
The entering data procedure was tested repeatedly in order to prevent any problems during the 
phase of active recruitment  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15 Example of MARK-AGE database interface 
 
3.6 PHENOTIPICAL VARIABLES ASSESSED BY MARK-AGE 
QUESTIONNAIRES AND INCLUDED IN THE ANALYSIS 
 
3.6.1 Socio-demographic Factors 
 
Data regarding present marital status, level of education and years of schooling, occupation, 
living condition (living at home or not) and cohabitation were included. Regarding the marital 
status the category “married” also took account of the live-in partners. The occupation was 
evaluated according to the ISCO classification (International Standard Classification of 
Occupation) and subjects were divided in “White Collars” (legislators, senior officials and 
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managers; professionals; technicians and associate professionals, clerks; service workers and 
shop and market sales workers; military), “Blue Collars ”(skilled agricultural and fishery 
workers; craft and related trades workers; plant and machine operators and assemblers; 
elementary occupations) and housekeepers (Cevenini et al., 2013). 
 
3.6.2 Lifestyle Factors 
 
Consumption of alcohol and smoke were considered. Regarding alcohol only everyday use 
was indicated. Concerning smoke the participants were divided in never smokers, former 
smokers, and smokers. 
 
3.6.3 Health Status 
 
Present health status was assessed asking subjects by which of the following diseases were 
affected: 
 Vision impairment 
 Hearing impairment 
 Neurological diseases 
 Angina pectoris  
 Irregular heart beat 
 Heart failure 
 High blood pressure (hypertension treated with prescribed drugs) 
 Venous insufficiency in legs/leg ulcers 
 Pain in leg during walking   
 Chronic respiratory diseases (COPD, asthma, chronic bronchitis etc.) 
 Chronic renal failure 
 High cholesterol 
 Diabetes 
 Hyperthyroidism 
 Hypothyroidism 
 Autoimmune Diseases (SLE, rheumatoid arthritis etc.) 
 Cirrhosis of the liver  
 Osteoporosis 
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 Arthritis 
 Serious memory impairments 
 Other mental health problems 
 
Other health problems not mentioned in the previous list were also recorded. The presence of 
past pathologies such as pneumonia, myocardial infarction, stroke, cerebral 
thrombosis/hemorrhage, malignant tumor and hip fracture was registered. The use of 
prescribed medicines along with the hospitalization (with an overnight stay) and the number 
of falls occurred in the last year were considered. Moreover the number of pathologies 
together with the number of medications used was analyzed.  
Self-reported health was classified using the following question from SF-36v1 Health Survey: 
“In general, would you say your health is?” with five-choice response scale (excellent, very 
good, good, fair and poor). Furthermore the subjects were clustered in “Healthy” (those who 
answered excellent, very good and good) and “Not Healthy (those who answered fair and 
poor). 
 
3.6.4 Disability  
 
The assessment was performed only on subjects over 60 years old using the Katz Index of 
activities of daily living (ADL) six-items scale (Katz et al., 1970). Only bathing, dressing, 
toileting, transfer and feeding were considered for categorization according to literature 
(Fillenbaum GG, 1996). Continence was analyzed separately. In compliance with Katz 
definitions (Katz et al., 1970) obtained data were distributed on a three level scale: 
 
Severely disabled (ADL = 0-2)  
Moderately disabled (ADL = 3-4) 
Not disabled (ADL = 5) 
 
The disability analysis was integrated with some questions from the Nagi-scheme (Nagi SZ, 
1976): reading newspaper without glasses or other aids, clearly recognize someone 4 metres 
away without glasses, hearing ability without aids, half a kilometer/a quarter of a mile 
walking without aids, going up and down a flight of stairs without anyone’s help, doing any 
kind of light housework or exercise, going outside with or without anyone’s help.  
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3.6.5 Functional status  
 
Physical performance was assessed with Chair Stand Test and Handgrip strength 
measurement. 
 
For Chair Stand Test the subjects were divided in three categories: able to perform the test, 
stop after 1-4 times and not able at all. Only the participants able to complete the test were 
considered for the analysis. Results of five times chair stand were reported as number of 
seconds spent to complete 5 chair stands. 
 
Handgrip strength was measured using a hand-held dynamometer (SMEDLYS’ 
dynamometer, Scandidact, Kvistgaard, Denmark) for three performances with each hand. The 
best performance of the dominant hand, in the able to perform volunteers, was used for the 
analysis (Gueresi et al., 2013).  
 
3.6.6 Anthropometric measurements 
 
The height measurement was performed with a common metre while the weight was 
measured using a common balance (SECA Mod. 761). Body mass index was calculated on 
weight and height data (K/m
2
). The subjects were divided for gender. 
 
3.6.7 Cognitive Status 
 
For the analysis were used only raw scores. 
 
Mini-Mental State Examination (SMMSE) 
 
This assessment (Molloy et al., 1991) was performed only on over 60 years old subjects The 
participants were divided in: 1.“severely impaired” (0–17 points), 2. “mild impaired” (18–23 
points) and “not impaired” (24–30 points) (Nybo et al., 2003). 
 
15 Picture Learning Test (15-PLT) 
 
The immediate and delayed memory function was assessed by the 15-Picture Learning Test 
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(Brand and Jolles, 1985). For the analysis were considered the sum of corrected pictures 
recalled immediately during the three consecutive trials and also the number of corrected 
pictures recalled after 20 minutes. A low score indicates worse cognitive performance. Only 
the tests reported as complete and reliable were used for the analysis. 
 
Stroop Colour Word Test  
 
The scores were the seconds necessary to complete the three trials of Stroop Colour Word 
Test (Stroop, 1935). A high score indicates worse performance.  
 
Digit Symbol Substitution Task (DSST) 
 
The processing speed assessed by the Digit-Symbol Substitution Task (Lezak et al., 2004) 
was scored using the number of correct digit-symbol combinations within 90 seconds. A low 
score indicates worse. Only the tests reported as complete and reliable were used for the 
analysis. 
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3.7 STATISTICAL ANALYSIS 
 
The database was cleaned to remove all the subjects whose nominal age was not in the 
appropriate range of the project. Most analysis was performed on a subset of the subjects of 
age over 60, to balance the effect of age and between different groups. 
 
For each test the subjects missing relevant parameter values were drop out. 
 
All the linear regressions were performed with a multivariate robust linear regression with a 
Huber’s T kernel and using age, gender and subject group as covariates. 
 
The regressions plot were done aggregating data by time range and representing their mean 
and standard deviation to ease visualization, and the region of confidence of the regression 
tendency of age are represented as shades. 
 
For categorical variable, the dependence with groups was tested with a Fisher exact test, 
found in the R statistical package. For categorical variable with dependence on continuous 
parameters like the age, a logistic test was performed, using age, gender and subject group as 
covariates. 
 
Few variables, like methylation status of ELOVL and FHL2, were calculated as the 
composition of different, related, partial parameters that are known to be related to the same 
phenomenon and are strongly correlated. These variables were combined through a mean, and 
the resulting value was used for all the following analysis. This approach leads to more robust 
and significant results than the analysis with any of the single variables. 
 
The analysis was performed with the Pyhton statistical libraries (statsmodels, seaborn, pandas, 
scipy) and the R statistical suite. 
 
In the performed statistical analysis Bonferroni-Sidak correction for multiple comparisons 
was applied. For this reason p values < 2.564e-04 will be considered statistically significant. 
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4. RESULTS 
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4.1 MARK-AGE RECRUITMENT ACCOMPLISHMENTS 
 
4.1.1 MARK-AGE recruitment in all the European centres 
 
As extensively explained before, the ambitious purpose of MARK-AGE project was to recruit 
a very consistent number of participants who were representative or assumed to have diverse 
rates of ageing in order to identify a group of ageing biomarkers able to quantify the 
biological ageing. 
MARK-AGE goal was largely achieved as a total of 3387 subjects were recruited. In 
particular 2336 RASIG, 566 GO, 323 SGO, 53 Down-Syndrome, 50 Werner Syndrome and 
59 Cockayne-Syndrome patients as shown in Table 4  
 
Table 4 number of volunteers recruited by the different centers 
 
RASIG population appeared to be well homogeneous distributed in the age classes and per 
gender (Fig16 and Fig18). 
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Fig. 16 RASIG distribution for age classes 
 
Contrary to the initial expectations the number of SGO subjects was about half of GO and this 
was mostly due to the fact that several GO subjects was singles, divorced or widowed or 
simply SGO were not eligible or declined MARK-AGE invitation.  
 
In spite of everything GO/SGO recruitment was a success since recruiters had to overcome 
many challenges in order to complete their task. As for RASIG participants also the 
distribution GO/SGO volunteers was homogeneous (Fig.17 and Fig.18). 
 
Fig. 17 GO-SGO distribution for age classes 
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Fig. 18 Distribution of the sample for groups and gender 
 
UNIBO recruitment unit was in charge of Down Syndrome individuals enrolment and was 
able to collect and characterize 53 subjects 
 
Regarding the collection of existing blood samples belonging to Cockayne-Syndrome patients 
DNage B.V. and later on University of Konstantz (UKON, Germany) were  responsible for 
the collection of about 59 samples. 
 
 
4.1.2 MARK-AGE recruitment in UNIBO 
 
The overall number of recruited volunteers in UNIBO was 627 (Table 5). It was undoubtedly 
an extraordinary result considering the complex procedures necessary to collect so different 
populations of GO, SGO, RASIG and Down Syndrome patients. In order to obtain the 
required number of volunteers a very large number of possible candidates was contacted and 
long distances were covered. Recruitment of GO e SGO subjects took place in almost the 
entire Emilia-Romagna region since it involved the counties of Bologna, Modena, Ferrara, 
Ravenna e Forlì-Cesena. The whole number of GEHA families contacted was 192 and 109 
GO plus 64 SGO were enrolled. As happened in the other recruitment centers also in UNIBO 
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the search of SGO candidates was very difficult and this is the reason why they represented 
only the 58.7% of GO recruited in UNIBO. 
RASIG recruitment was performed in the small town of Pianoro (a little city near Bologna) 
and within Bologna University employees and their relatives and friends. The total number of 
subjects contacted was 779, of those 482 amid Pianoro population while the other 296 were 
contacted among the Bologna University staff.  
Volunteers affected from Down Syndrome were recruited involving specific associations, 
families along with psychologists and psychiatrists. 
 
 
Table 5 Mark-Age recruitment in UNIBO 
 
 
4.1.3 The Re-Sampling Phase 
 
A re-sampling was performed on 108 volunteers from the whole study population, as shown 
in Table 6 and this was done to confirm the biological and analytical robustness of the 
measurements. University of Konstantz (UKON, Germany) randomly selected a list of 
PrimaryID of the recruited probands (GO, SGO and RASIG of both sexes) that had to be re-
tested and sent it to all beneficiaries involved in the recruitment. 
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Table 6 number of subjects re-sampled 
 
 
4.1.4 The Re-Testing Phase 
 
After 3 years a mini-longitudinal study was performed re-testing a limited number of GO, 
SGO and RASIG subjects (only the 12% of recruited volunteers was involved) in order to 
validate the predictive power of specific biomarkers. 405 subjects in total were once again 
assessed using the complete standard procedure applied for the first assessment (Table 7). 
 
 
 
 
 
 
 
 
 
 
 
Table 7 Numbers of re-tested volunteers 
 
Also in this case University of Konstantz (UKON, Germany) randomly selected the subjects 
for the re-testing.  
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4.2 CHARACTERIZATION OF THE SELECTED SAMPLE ANALYZED  
 
4.2.1 Composition of the sample  
 
The sample used in this dissertation was stratified on the basis of age ≥ 60 yrs, thus 1598 
volunteers aged 60 – 79 years were constituted as follows: 1. 420 GO (179 males and 241 
females), 2. 231 SGO (134 males and 97 females) and 3. 947 RASIG (470 males and 477 
females). The sample is homogeneously divided in males (49%) and female (51). The number 
of RASIG subjects divided per gender was similar, on the contrary GO and SGO were more 
unbalanced (Table 8). 
 
 
 
Due to incompleteness of MARK-AGE database the number of subjects analyzed in this 
dissertation shifts between 1573 and 1598. 
 
 
 
 
Table 8 Composition of the  analyzed sample (N=1598) divided for gropus, gender and age classes 
       
 Total N % 
Gender       
 Male  783   49  
 Female  815   51  
        
     
  GO (n=420) SGO (n=231) RASIG (n=947) 
     
  N Male N Female N Male N Female N Male N Female 
Gender distribution for age classes       
 60-64 72 83 41 54 170 162 
 65-69 72 104 59 38 155 164 
 70-74 35 47 27 4 143 147 
 75-79 0 7 7 1 2 4 
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4.2.2 Socio-demographic characteristics 
 
4.2.2.1 Marital status 
 
From the marital status data obtained, most of the participants was married even though the 
RASIG showed the lowest percentage (68%). On the contrary RASIG population had a higher 
number of separate/divorced (13.9%) and widow/widower volunteers (12.8). Never married 
share was higher in GO participants. Separating data according gender, the number of married 
females was lower than males while the number of never married, separated/divorced or 
widow females (GO and RASIG) was higher as expected (Table 9 ). 
 
 
 
4.2.2.2 Level and years of education 
 
The level of literacy among the volunteers was high and almost the totality of the sample 
received a formal education (only 0.4% of RASIG subjects never went to school and less of 
2% of volunteers didn’t complete elementary school level) even though on a different level. 
Examining the number of years spent in school the percentages are quite similar between 
Table 9 Marital status  divided for groups and gender 
     
  GO  SGO  RASIG  
     
  N  % N  % N  % 
       
Marital status       
 Never married   32   7.6 4 1.7 50 5.3 
 Married 316 75.2 220 95.2 644 68 
 Separated/Divorced   38   9.1 3 1.4 132 13.9 
 Widow/widower   34   8.1 4 1.7 121 12.8 
        
  MALES FEMALES 
Marital status per gender   
  GO 
% 
SGO 
% 
RASIG 
% 
GO 
% 
SGO 
% 
RASIG 
%   
        
 Never married 6.2 1.5 2.8 8.8 1 7.8 
 Married 84.9 96.3 82.7 68 94.9 53.4 
 Separated/Divorced 5.6 1.5 9.8 11.6 1 18 
 Widow/widower 3.3 1.5 4.7 11.6 2 20.7 
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males. SGO and RASIG females reported a slightly lower amount of schooling years than GO 
females whose values were comparable with males. (Table. 10) 
 
 
 
4.2.2.3 Occupation 
 
Great part of the sample declared to have an occupation during his life (96.7% GO, 92.9% 
SGO and 95.3% RASIG) (Table.11). The majority of subjects belonged to “White Collars” 
category with percentages very similar (shifting between 75.6% and 80%). The number of 
housekeepers was very low with the highest percentage in RASIG volunteers (6.2%). 
Considering the gender, the percentage of employed males subjects resulted higher (100% 
GO, 99.2% SGO and RASIG 99.6%) than females (94.2% GO, 93.8% SGO and only 1.2% 
RASIG). “White collars” occupation was predominantly in females volunteers even though 
in SGO females the percentage of “Blue Collars” occupation was higher than in the other 
Table 10 Education level Education level and years of schooling divided for groups and gender 
    
  MALES FEMALES 
     
  GO 
Mean ± DS 
SGO 
Mean ± DS 
RASIG 
Mean ± DS 
GO 
Mean ± DS 
SGO 
Mean ± DS 
RASIG 
Mean ± DS 
       
Education: number of years 12.8 ± 5.2 12.8 ± 5.1 12.9 ± 4.3 12.6 ± 5 11.1 ± 5.0 11.7 ± 4.1 
        
        
  GO 
% 
SGO 
% 
RASIG 
% 
GO 
% 
SGO 
% 
RASIG 
% 
        
Education level       
 Never went to school 0 0 0 0 0 0.8 
 Did not finish elementary 
school 
0 1.5 1.5 0 0 1.7 
 Finished elementary school   10.1 6.7 12.8 9.1 18.5 19 
 First stage of secondary 
level education 
27.4 23.9 11.7 26.1 28.9 16.1 
 Second stage of secondary 
level education 
20.7 21.6 22.5 22.4 23.7 19.1 
 Third level education other 
than university degree   
12.9 17.2 13.8 17.4 13.4 22.6 
 Initial university degree or 
recognized equivalent 
10.1 5.2 18.1 7.1 4.1 8.6 
 Higher university degree or 
post graduate 
17.9 22.4 19.6 17 11.3 11.3 
 Do not know       1.1 1.5 0 0.8 0 0.6 
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groups. Moreover, as expected, a much higher percentage of housekeepers was present among 
females and in particular in RASIG females. 
 
 
 
4.2.2.4 Living condition 
 
The majority of the interviewed subjects lived in a private residence, house (included town 
house), farm or apartment (97.4% GO, 96.5% SGO, 99.4% RASIG) in comparable 
percentages for males and females. Very small indeed was the amount of the participants 
living in special dwelling for elderly or other kind of abodes. No subjects lived in nursing 
homes or residential care. (Table 12) 
Moreover considering the cohabitation aspect, the majority of volunteers shared their 
domicile with their spouse, offspring, other relatives or friends (83.6% GO, 98.3 SGO, 76.4% 
RASIG). Noteworthy was the difference between the number of GO and RASIG subjects who 
lived alone (16.4% versus 23.6%).  Regarding this point, splitting the data according to 
gender, the differences between GO and RASIG group were evident in males (7.2% GO, 
RASIG 12.8%) and even more noticeable in females (23.2 GO and 34.4 RASIG).  
Table 11 Main occupation classification divided for groups and gender 
     
  GO SGO RASIG 
        
  N % N N % N 
       
 White collars 336 80 174 75.6 745 78.8 
 Blue collars 67 16 51 22.2 141 15 
 Housewives 17 4 5 2.2 59 6.2 
        
  MALES FEMALES 
  
GO 
% 
SGO 
% 
RASIG 
% 
GO 
% 
SGO 
% 
RASIG 
%   
        
 White collars 74.3 75.4 79.6 84.2 76.2 78 
 Blue collars 25.1 23.9 18.9 9.2 21.5 11 
 Housewives 0.6 0.7 1.5 6.6 4.1 11 
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4.2.3 Lifestyle Factors 
 
About half of the examined samples never smoked (48.6% GO, 45.9% SGO, 51.6% RASIG) 
while the other half consisted mostly in former smokers with a small quota of subjects who 
were currently smoking (Table 13). Only one-third of the sample was currently drinking 
alcohol every day (wine, beer or other alcoholic beverages) with comparable percentages 
between groups. The amount of total alcohol intake wasn’t considered. 
 
 
Table 12 Living condition – Housing and cohabitation divided for groups and gender 
     
  GO SGO RASIG 
        
  N % N % N % 
Housing       
 House, farm, apartment 409 97.4 223 96.5 943 99.4 
 Special dwelling for elderly 0 0 1 0.4 2 0.2 
 Nursing home 0 0 0 0 2 0.2 
 Other 11 2.6 7 3 3 0.3 
        
Cohabitation       
 With others 351 83.6 227 98.3 723 76.4 
 Alone 69 16.4 4 1.7 224 23.6 
        
  MALES FEMALES 
  
GO 
% 
SGO 
% 
RASIG 
% 
GO 
% 
SGO 
% 
RASIG 
%   
Housing       
 House, farm, apartment 97.8 95.5 99.8 97.1 97.9 99.2 
 Special dwelling for elderly 0 0.7 0 0 0 0.4 
 Nursing home 0 0 0 0 0 0 
 Other 2.2 3.7 0.2 2.9 4.1 0.4 
        
Cohabitation       
 With others 92.8 98.5 87.2 76.8 97.9 65.6 
 Alone 7.2 1.5 12.8 23.2 2.1 34.4 
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4.2.4 Health Status 
 
4.2.4.1 Health and morbidity 
 
Analysing data referred to present pathologies, sensorial deficits were surely the most 
recurrent health problems among the interviewed volunteers and in particular vision 
impairment was the most  frequent in the three groups: (48.3% GO, 42% SGO, 71% RASIG)  
Table 13 Lifestyle habits divided into groups 
     
  GO  SGO  RASIG  
     
  N  % N  % N  % 
       
Smoking       
 Never smokers 204 48.6 106 45.9 489 51.6 
 Former smokers 171 40.7 105 45.4 345 36.4 
 Smokers 45 10.7 20 8.7 113 12 
        
Drinking        
 Every day (wine, beer etc.) 129 30.7 73 31.6 286 30.2 
        
Table 14a Health status and morbidity distribution between groups  
      
  GO  SGO  RASIG  P values 
      
  N  % N  % N  %  
Present diseases        
 Vision impairment 201 48.3 95 42 673 71 0.000500 
 Hearing impairment   72 17.4 35 15.3 201 21.3 0.047476 
 Neurological diseases 12 2.9 5 2.2 25 2.6 0.908546 
 Angina pectoris  15 3.6 21 9.2 61 6.5 0.012494 
 Irregular heart beat   31 7.5 33 14.5 120 12.7 0.003998 
 Heart failure    12 2.9 14 6.2 49 5.2 0.096952 
 High blood pressure  111 26.7 71 31.4 388 41 0.000500 
 Venous insufficiency in legs  54 12.9 24 10.4 122 12.9 0.607696 
 Pain in leg during walking   51 12.2 30 13 156 16.5 0.084958 
 Chronic respiratory 
diseases 
32 7.6 13 5.6 68 7.2  0.676662 
 Chronic renal failure    2 0.5 1 0.5 7 0.7 0.913543 
 High cholesterol    111 26.7 76 32.9 348 37 0.001000 
 Diabetes   24 5.7 16 7 73 7.7 0.444278 
 Hyperthyroidism    11 2.6 4 1.8 28 3 0.648676 
 Hypothyroidism   29 6.9 13 5.7 109 11.6 0.001999 
 Autoimmune Diseases  7 1.7 6 2.6 47 5 0.006997 
 Cirrhosis of the liver  2 0.5 0 0 2 0.2 0.636182 
 Osteoporosis 40 9.6 18 7.9 127 13.5 0.017491 
 Arthritis  124 29.7 61 26.7 268 28.3 0.725137 
 Serious memory 
impairments  
3 0.7 0 0 12 1.3 0.219890 
 Other mental health 
problems   
11 2.6 8 3.5 25 2.6 0.764618 
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Performing a logistic regression is clearly visible that the impairment present in RASIG 
volunteers was extremely significant and age independent (Table 14b). The statistical model 
is constructed in order to predict the probability of development of pathology. Through 
logistic regression is possible to highlight the difference between RASIG and GO and also 
between SGO and GO.  
 
 
 
 
 
 
 
 
Hearing impairment was less represented but also in this case RASIG group was the most 
affected (21.3%). Females resulted to be more compromised than males.  
Table 14b Vision impairment logistic regression corrected for groups, gender 
and age 
 coef pvalues relative risk 
Intercept      -1.135547 0.178 0.321246 
Gender[T.M]   -0.250503 0.0196 0.778409 
Subject_Group[T.RASIG] 0.974715 1.83e-15 2.650412 
Subject_Group[T.SGO] -0.210161 0.211 0.810454 
Age 0.017769 0.161 1.017927 
Table 15 Health status and morbidity per gender and groups  
      
  MALES  FEMALES  
       
  GO 
% 
SGO 
% 
RASIG 
% 
P values GO 
% 
SGO 
% 
RASIG 
% 
P values 
Present diseases           
 Vision impairment 42.6 39.4 69.3 0.000500 52.5 45.7 72.7 0.000500 
 Hearing impairment   19.4 20.1 23.8 0.361819 15.9 8.4 18.7 0.036982 
 Neurological diseases 3.3 3.7 3.4 0.966017 2.5 0 1.9 0.327336 
 Angina pectoris  3.9 13.5 8.4 0.006997 3.3 3.1 4.4 0.817091 
 Irregular heart beat   7.3 17.3 11.5 0.028986 7.6 10.5 13.8 0.040480 
 Heart failure    3.3 10.6 5.7 0.037981 2.55 0 4.6 0.041979 
 High blood pressure  27.5 30.3 41.3 0.001000 25.9 33 39.9 0.001000 
 Venous insufficiency in 
legs  
8.9 5.2 6.8 0.452274 27.1 17.5 18.9 0.618191 
 Pain in leg during walking   10.7 15 13 0.519740 13.4 10.3 20 0.018491 
 Chronic respiratory 
diseases 
7.9 8.9 5.3 0.202899 7.5 1 9 0.008996 
 Chronic renal failure    1.1 0.7 0.6 0.848076 0 0 0.8 0.431784 
 High cholesterol    24.1 32.1 33.7 0.063968 28.4 34 40.2 0.008496 
 Diabetes   7.3 6.7 7.7 0.982009 4.6 7.3 7.8 0.260370 
 Hyperthyroidism    0 0.8 2.1 0.073963 4.6 3.1 3.8 0.852074 
 Hypothyroidism   5.6 2.3 4.3 0.381309 7.9 10.3 18.8 0.000500 
 Autoimmune Diseases  1.1 3 4.3 0.117441 2.1 2.1 5.7 0.048976 
 Cirrhosis of the liver  0.6 0 0.2 0.645677 0.4 0 0.2 1.000000 
 Osteoporosis 2.2 0.8 2.1 0.660170 15 17.5 24.6 0.005997 
 Arthritis  23.6 21.2 21.9 0.866067 34.1 34 34.7 0.993003 
 Serious memory 
impairments  
0.6 0 1.5 0.410295 0.8 0 1.1 0.873063 
 Other mental health 
problems   
1.7 3 1.7 0.536732 3.3 4.2 3.6 0.932534 
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Regarding the presence of cardiovascular diseases GO group seemed to be better protected 
against arrhythmia, angina pectoris and heart failure since it showed the lower prevalence 
percentages.  
 
Analysing data considering gender SGO males situation is surely noteworthy since they 
presented the higher values for arrhythmia, angina pectoris and heart failure (table 15).  
 
Clusterizing reported cardiovascular pathologies (angina pectoris, hypertension, irregular 
heartbeat, heart failure) and performing a logistic regression, RASIG subjects proved to have 
the worst cardiovascular status and it tends to worsen with age with a very high relative risk 
(Table 15b).  
 
 
 
 
 
 
 
 
 
 
Adding the presence of a previous myocardial infarction to the cardiovascular cluster RASIG 
situation worsen with values more significant than before. 
 
 
 
 
 
 
 
 
 
Moreover with regard to risk factors predisposing to cardiovascular diseases or that can 
aggravate their progression such as hypertension, hypercholesterolemia and diabetes, the first 
Table 15b Cardiovascular cluster logistic regression corrected for groups, 
gender and age 
    
 coef pvalues relative risk 
Intercept      -5.696023 4.3e-12 0.003359 
Gender[T.M]   0.123640 0.233 1.131608 
Subject_Group[T.RASIG] 0.590077 1.92e-06 1.804128 
Subject_Group[T.SGO] 0.397393 0.0211 1.487941 
Age 0.075362 8.15e-10 1.078275 
    
Table 15c Cardiovascular cluster plus previous infarction logistic regression  
corrected for groups, gender and age 
    
 coef pvalues relative risk 
Intercept      -5.600465 9.67e-12 0.003696 
Gender[T.M]   0.145990 0.159 1.157185 
Subject_Group[T.RASIG] 0.610602 8.34e-07 1.841539 
Subject_Group[T.SGO] 0.408837 0.0175 1.505066 
Age 0.073818 1.77e-09 1.076611 
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two were very frequent among all participants and mainly in RASIG volunteers (41%), while 
diabetes was less represented but also in this case RASIG percentage was higher than in the 
other groups.  
 
Clusterizing reported hypertension, hypercholesterolemia and diabetes and performing a 
logistic regression RASIG confirmed their difficulties and the situation is worsened by age 
(Table 15d). 
 
 
 
 
 
 
 
 
 
 
Muscle-articular apparatus disorders were reported by almost one-third of volunteers and 
females belonging to all groups reported the highest percentages (table 15). Concerning the 
presence of osteoporosis on the whole sample, only a small percentage of subjects was aware 
of being affected and RASIG group seemed to be more afflicted; as expected females 
volunteers (without distinction of group) had the highest prevalence. The past history of hip 
fracture, which correlates with osteoporosis, was present in a very limited number of subjects. 
Clusterizing reported articular pathologies (osteoporosis, arthritis and back-pain) and 
performing a logistic regression is confirmed that females has the worst condition 
 
 
 
 
 
 
 
 
Table 15d Metabolic cluster logistic regression corrected for corrected for 
groups, gender and age 
    
 coef pvalues relative risk 
Intercept      -3.678481 6.94e-06 0.025261 
Gender[T.M]   -0.060699 0.557 0.941107 
Subject_Group[T.RASIG] 0.587252 1.02e-06 1.799038 
Subject_Group[T.SGO] 0.343320 0.0406 1.409620 
Age 0.053608 1.26e-05 1.055071 
Table 15e Articular cluster logistic regression corrected for groups, gender and 
age 
    
 coef pvalues relative risk 
Intercept      -2.315233 0.00443 0.098743 
Gender[T.M]   -0.866171 6.96e-17 0.420559 
Subject_Group[T.RASIG] 0.107460 0.376 1.113446 
Subject_Group[T.SGO] -0.108760 0.523 0.896946 
Age 0.039691 0.00118 1.040489 
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The presence of chronic respiratory diseases such as COPD, asthma or chronic bronchitis is 
reported by a small number of candidates with percentages ranged between 5.6% and 7.2%. 
SGO females seemed to be the less affected (only 1%). The prevalence of leg venous 
insufficiency was comparable between groups but focusing on gender it appeared to be 
prerogative of females, as expected, and especially GO females (27.1%). Regarding the 
manifestation of leg pain during walking also known as Peripheral Artery Disease (PAD), a 
circulation problem in which the arteries in the legs become narrowed or blocked reducing the 
amount of oxygen that gets to the limbs, it seemed to affect mostly RASIG volunteers 
(16.5%) and in particular RASIG females (20%).  
 
With regard to thyroid function, hyperthyroidism was scarcely present in all on the contrary 
hypothyroidism was reported in higher values and mostly by RASIG group. As expected, 
hyper and hypothyroidism affected mainly female volunteers and particularly RASIG females 
had the highest hypothyroidism prevalence. 
 
Examining data referred to pathologies occurred in the past (Table 16), about one-fifth of the 
sample, with values ranging between 15.6% (GO) and 20.3% (SGO), reported at least one 
episode of pneumonia but this raw data does not differentiate between who contracted it at 
young age and  who contracted it at older age.  
 
Table 16 Health status and morbidity 
     
  GO  SGO  RASIG  
     
  N  % N  % N  % 
        
Past diseases       
        
 Pneumonia  65 15.6 47 20.3 173 18.3 
 Myocardial infarction  8 1.9 13 5.7 40 4.2 
 Stroke, cerebral thrombosis 15 3.6 9 3.9 30 3.2 
 Malignant Tumour  16 3.8 10 4.3 29 3.1 
 Hip fracture  9 2.2 3 1.3 16 1.7 
       
Other not mentioned health problems 97 23.1 48 20.9 247 26.2 
       
Use of prescribed medicines  278 66.7 160 70.2 693 73.2 
     
Hospitalization in the last year 49 11.7 30 13 137 14.5 
        
Falls in the last year 56 13.5 27 11.7 117 12.4 
        
Loss of weight in the last year 139 33.17 74 32 323 34.2 
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The prevalence of previous myocardial infarction was quite low among volunteers and GO 
seemed to be more protected than SGO and RASIG (Table 16) but taking into account  
gender, it is important to point out that actually all females, without distinction, were less 
affected than males.  
 
Performing a logistic regression on previous myocardial infarction data, as expected, males 
were the most affected (Table 16b). 
 
 
 
 
 
 
 
 
 
 
The occurrence of stroke and cerebral thrombosis was comparable between groups and 
gender. Regarding previous cancer, GO females reported the highest prevalence. Noteworthy 
was the number of volunteers (more than one-fifth of the sample) declaring to have other 
       
 MALES FEMALES 
   
 GO 
% 
SGO 
% 
RASIG 
% 
GO 
% 
SGO 
% 
RASIG 
%  
Past diseases       
        
 Pneumonia  18 24.6 17.5 13.8 14.4 19.1 
 Myocardial infarction  2.8 9 6.8 0.8 1 1.6 
 Stroke, cerebral thrombosis 4 5.3 2.8 3.3 2.1 3.6 
 Malignant Tumour  7.3 9.7 7.5 12 8.2 7 
 Hip fracture  2.8 1.5 1.1 1.6 1 2.3 
        
Other not mentioned health problems 25.1 26.1 25.1 21.6 13.6 27.3 
       
Use of prescribed medicines  63.1 70.7 68.1 68.9 69.5 78.2 
        
Hospitalization in the last year 13.4 15.7 15.8 10.4 9.3 13.3 
        
Falls in the last year 10.7 8.2 8.1 15.5 16.5 16.6 
        
Loss of weight in the last year 27.9 29.1 30.1 37.1 36.1 38.3 
       
Table 16b Previous myocardial infarction logistic regression corrected for 
groups, gender and age 
    
 coef pvalues relative risk 
Intercept      -8.649374 3.49e-05 0.000175 
Gender[T.M]   1.517001 7.8e-06 4.558533 
Subject_Group[T.RASIG] 0.812315 0.0518 2.253118 
Subject_Group[T.SGO] 1.030882 0.0323 2.803537 
Age 0.055239 0.0712 1.056793 
61 
medical conditions in addition to those investigated (23.1% GO, 20.9% SGO, 26.2% RASIG). 
Unexpectedly, only 13.6% of SGO females reported additional pathologies. 
 
As harbingers of incipient decay of the physical performance the presence of three events 
occurred in the last 12 months were investigated:  
 
1. Number of falls 
2. Hospitalization (with an overnight stay) 
3. Loss of weigh 
 
Concerning the falls no significant differences were found since volunteers showed 
comparable percentages (13.5% GO, 11.7% SGO, 12.4% RASIG) even though females 
reported higher prevalence (without distinction of group). The percentage of volunteers 
subjected to hospitalization shifted between 11.7% (GO) and 14.5% (RASIG) and the number 
of hospitalized males was higher than females. Concerning weight, data showed that one-third 
of the sample referred loss of weight in the last year in comparable percentages among groups 
while females showed the highest percentages. Unfortunately it was not reported if the loss of 
weight was intentional (e.g. due to diet or physical exercise) or not. 
 
An assessment of health status at the time of the interview, described on the basis of the 
presence of disease and use of drugs was performed.  
 
Multimorbidity or the presence of two or more medical conditions within the same individual 
is an extremely recurrent event in the elderly. For this reason the number of pathologies 
reported by volunteers was analysed (Table 17). The number of pathologies ranged between 
2.5 (GO) and 4.2 (RASIG) per capita. Data pointed out that RASIG subjects were 
significantly more affected than the other groups while no substantial difference was found 
between GO and SGO. Considering gender, in all three groups females showed a higher and 
significant morbidity. As expected, age played an important role (Table 18). 
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Fig. 19 Distribution of the number of pathologies in groups and gender 
 
 
 
 
 
 
 
 
 
 
Table 17 Number of pathologies divided into groups and gender  
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 179 2.519553 1.972681 0 1 2 4 8 
 F 241 3.161826 2.139596 0 2 3 4 11 
          
SGO M 134 2.798507 2.386616 0 1 2 4 12 
 F 97 3.072165 2.416296 0 1 3 5 10 
          
RASIG M 470 3.206383 2.064514 0 2 3 4 11 
 F 477 4.215933 2.497376 0 2 4 6 17 
          
Table 18 Linear regression of number of pathologies 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      -3.143558 0.000236 -4.819413 -1.467702 
Subject_Group[T.RASIG] 0.742504 6.24e-09 0.492030 0.992979 
Subject_Group[T.SGO] 0.048794 0.785 -0.300994 0.398581 
Gender[T.M]   -0.777255 1.02e-12 -0.990978 -0.563531 
Age 0.094836 1.51e-13 0.069672 0.120001 
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The relation between number of pathologies and age was investigated in order to estimate the 
effect of age on the three different groups of volunteers (Table 19). To better address the 
problem the whole RASIG population (younger volunteers included) was considered.  
 
 
 
 
 
 
 
 
 
 
 
As expected age had a tremendous and significant impact on multimorbidity especially on 
females as reported in literature. As seen before, RASIG population showed a significant 
worse situation with respect to GO and SGO who, on the contrary displayed no significant 
differences (Table 19). In fact, observing the distribution of morbidities in the three groups, it 
is clearly evident an increase with age apparently more strong in RASIG (Fig. 20). 
 
Fig. 20 Number of pathologies linear regression 
Since medication use in the elderly is an important issue, the percentage of volunteers 
reporting use of prescribed medicines was considered. The percentages found were very high 
spanning from 66.7% of GO to 70.2% of GO up to an impressive 73.2% of RASIG who also 
in this occasion were confirmed as the subjects in the worst situation. Considering that poly-
Table 19 Number of pathologies and age linear regression corrected for group and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      -2.066621 4.22e-19 -2.520146 -1.613097 
Subject_Group[T.RASIG] 0.625992 6.94e-11 0.437867 0.814116 
Subject_Group[T.SGO] 0.018699 0.891 -0.248242 0.285640 
Gender[T.M]   -0.628531 4.85e-20 -0.762912 -0.494151 
Age 0.079028 2.63e-121 0.072414 0.085641 
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pharmacy is increasing among older people the number of medications used was analysed 
(Table 20). 
 
 
The analysis showed that the number of medications used ranged between 1.76 (GO) and 2.59 
(RASIG) per capita. RASIG subjects showed a worse situation and in particular RASIG 
females who reported the highest numbers of medicine used (Fig. 21). 
 
 
 
 
 
 
 
 
 
 
Fig. 21 Distribution of number of medicines used divided for groups and gender 
 
As previously done with pathologies, the correlation between number of medications used 
and age was examined (Table 21). Also in this case, as predicted, age showed a crucial impact 
but unexpectedly no significant difference was found between males and females. RASIG 
group confirmed, also in this occasion, to be the group with more difficulties (Fig. 22).  
 
Table 20 Number of medicines used divided for groups and gender  
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 179 1.765363 2.069231 0 0 1 3 9 
 F 241 1.804979 2.010218 0 0 1 3 10 
          
SGO M 134 2.320896 2.363891 0 0 2 4 10 
 F 97 2.000000 2.005202 0 0 2 3 9 
          
RASIG M 470 2.104255 2.217344 0 1 2 4 10 
 F 477 2.597484 2.363375 0 0 2 3 10 
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Fig. 22 Number of medicines and age linear regression 
 
All the clinical parameters examined so far were self-reported and this could suggest that the 
prevalence of certain diseases could be higher than registered because the subjects may be not 
aware of being affected. In order to test this hypothesis two parameters as 
hypercholesterolemia and diabetes were explored. For this analysis self-reported prevalence, 
specific medication use and serum cholesterol level >6.2 mmol/l (for hypercholesterolemia) 
and serum glucose level > 6.9 mmol/l (for diabetes) were considered (Fig. 23). The glucose 
and cholesterol serum level was included in the evaluation in order to found undetected cases 
of metabolic diseases. The test was performed on the whole GO, SGO and RASIG population 
combined (considering all age classes) and it showed clearly that, besides an expected age 
related increase of total prevalence, very considerable was the quota of subjects that appears 
to be affected by metabolic pathologies without being aware of (Fig. 23). 
Table 21 Number of medicines and age linear regression corrected for group and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      -4.567761 5.27e-09 -6.101195 -3.034327 
Subject_Group[T.RASIG] 0.463646 7.34e-05 0.234458 0.692834 
Subject_Group[T.SGO] 0.455377 0.00529 0.135316 0.775438 
Gender[T.M]   -0.269686 0.00687 -0.465246 -0.074125 
Age 0.095165 5.48e-16 0.072139 0.118191 
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Fig.23 Total prevalence of hypercholesterolemia and diabetes by age classes in GO, SGO and RASIG 
volunteers. The white colour indicates the unknown prevalence based only on serum levels. 
 
4.2.4.2 Self-reported health  
 
 
It is well known in literature that self-reported health status is a good predictor of forthcoming 
disability, hospitalization and mortality (Idler et al. 1995, Idler et al. 1997, Gold et al. 1996, 
Miilunpalo et al. 1997, Jamoom et al. 2008). It was estimated the level of perceived health 
status with the following question from SF-36v1 Health Survey: “In general, would you say 
your health is”. The percentages of five-choice response scale (excellent, very good, good, 
fair and poor) were considered for the analysis. 
 
Almost one-third of the subjects judged to have a “very good” health status (SGO had the 
lower percentage) while more or less half of the sample and in particular SGO volunteers 
considered their health as “good” (Table 22). Considering the extremes of the scale, the 
“excellent” and the “poor” health status, GO subjects reported the highest percentage of 
“well-being” (14.5%) declared as “excellent” health status and the lowest percentage of 
“illness” (0.5%) considered as “poor”. On the contrary RASIG volunteers reported the lowest 
percentage of “well-being” (9.2%) while SGO reported the worst health status. Considering 
the gender variable, the “excellent” health status was reported mainly by males subjects (with 
GO in the frontline) compared to females (in particular RASIG females). The percentages of 
“poor” health status of GO were the lowest (males and females) while were the highest into 
SGO and RASIG males. 
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The five-choice response scale was clustered in two groups:  
 
1. “Healthy” including those who considered their health status good, very good and 
excellent. 
2. “Not healthy” including those who considered their health status fair and poor. 
 
 
 
The majority of GO volunteers (86%) were convinced to have a “healthy” status compared to 
RASIG (83.3%) and SGO subjects (81.3%). Considering the number of subjects who had 
perception of “poor” health status SGO volunteers had the highest percentages (Table 22). 
 
The possible correlation between perceived health status and age was explored and no 
significant data was found (Table 23). 
 
 
 
Table 22 Self-reported Health Status 
     
  GO  SGO  RASIG  
     
  N  % N  % N  % 
        
Self-reported health       
 Excellent 61 14.5 23 10 87 9.2 
 Very good 123 29.3 54 23.4 305 32.2 
 Good 177 42.1 111 48 397 42 
 Fair 57 13.6 35 15.1 136 14.3 
 Poor 2 0.5 8 3.5 22 2.3 
        
Self-reported health       
 Healthy 361 86 188 81.3 789 83.3 
 Not healthy 59 14 43 18.7 158 16.7 
        
  MALES FEMALES 
    
  GO 
% 
SGO 
% 
RASIG 
% 
GO 
% 
SGO 
% 
RASIG 
%   
        
Self-reported health       
 Excellent 17.3 10.4 10.8 12.5 9.3 7.5 
 Very good 28.5 23.9 34 29.5 22.7 30.4 
 Good 39.1 47 40.8 44.5 49.5 43 
 Fair 14.5 14.2 11.5 12.9 16.5 17.2 
 Poor 0.6 4.5 2.8 0.5 2 1.9 
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4.2.5 Disability  
 
4.2.5.1 ADL  
 
Aging process is very frequently characterized by disability. The level of disability was 
evaluated with Katz ADL Scale (continence excluded) and the obtained results were 
categorized with a three level scale where the volunteers were classified as not impaired, 
moderately impaired and severely impaired (Table 24). Almost the entire sample was 
completely independent with comparable data between the three groups. Considering gender, 
very small percentages of GO males (1.1%) and SGO females (1%) showed to be severely 
impaired. The differences found between groups, males and females were no significant.  
 
A said before, the continence item from Katz’s Scale was considered separately from the 
others items (Table 25). 
Table 23  healthy” volunteers and age logistic regression corrected for group and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      4.182376 8.98e-05 2.089364 6.275388 
Subject_Group[T.RASIG] -0.185332 0.266 -0.511610 0.140945 
Subject_Group[T.SGO] -0.376122 0.0896 -0.810353 0.058110 
Gender[T.M]   0.186734 0.174 -0.082189 0.455658 
Age -0.036929 0.0204 -0.068151 -0.005708 
     
Table 24 ADL scale  
     
  MALES FEMALES 
    
  GO 
% 
SGO 
% 
RASIG 
% 
GO 
% 
SGO 
% 
RASIG 
%   
        
ADL       
 Severely impaired (ADL=0-2) 1.1 0 0 0.4 1 0 
        
 Moderately impaired (ADL=3-4) 0.6 0.7 0.2 0.4 1 0 
        
 Not impaired (ADL=5) 98.3 99.3 99.8 99.2 98 100 
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Incontinence problems were higher in GO volunteers (17.7%) than in SGO (14.8%) and 
RASIG (13.2%) however no significant difference was found. Analysing data considering 
gender, as expected, incontinence was a female prerogative in fact the problem was present in 
22.5% of females against 6.5% of males. In this case a significant difference was found. 
 
 
4.2.5.2 Nagi-scheme 
 
The analysis of disability was enriched with the evaluation of several questions from the 
Nagi-scheme (Nagi SZ, 1976) evaluating the sensorial and physical abilities. 
 
Almost one-fifth of the sample was able to read newspaper without glasses even though SGO 
(17%) showed to have more difficulty than GO (20.2%) and RASIG (21.6%) and a very high 
number of subjects was able to recognize someone 4 m far away without glasses (Table 26). 
Also in this case SGO (81.2%) had more difficulty than GO (86.6%) and RASIG (86%). 
Nearly the entire sample had no difficulties in hearing without aids with comparable 
percentages among groups. 
 
Regarding functional status all the sample seemed to be completely independent and without 
particular difficulties (Table 26). The percentages of subjects able to walk for about 500 m 
without aids ranged between 97.1% (GO) and 99.6% (RASIG) The same applied for the 
ability of going up and down the stairs without anyone’s help where 98.3 % of GO and SGO 
and 99.9of RASIG subjects showed no difficulties. Also the ability of doing any kind of light 
housework or exercise was completely conserved by almost all the sample (Table 26). 
Table 25 Evaluation of continence  
      
  GO  SGO  RASIG  pvalues 
      
  N  % N  % N  %  
         
Continence        
 Leak urine 74 17.7 34 14.8 117 13.2 
0.09295 
 Full continence 343 82.3 196 85.2 772 86.8 
         
  MALES FEMALES  
     
 Leak urine 6.5 22.5 
2.2e-16 
 Full continence 93.5 77.5 
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4.2.6 Functional status  
 
The volunteers functional status was tested with Chair Stand Test and measuring the handgrip 
strength. 
 
4.2.6.1 Chair Stand Test 
 
Firstly was evaluated candidates ability to perform the exercise without problems. Subjects 
were divided in three categories: ability to perform the exercise without difficulties, necessity 
to stop after 1-4 times and not able at all to perform (Table 27).  
The majority of the sample was able to complete test exercise without problems and only very 
few subjects had to stop before the test end. Very small percentages of GO (2.6%) and 
RASIG (2.7%) were not able at all to perform the exercise. 
 
Table 26 Sensorial and functional status 
     
  GO  SGO  RASIG 
     
  N  % N  % N  % 
        
Nagi Scheme       
 Reading newspaper without 
glasses 
85 20.2 39 17 203 21.6 
 Recognize someone 4 m away 
without glasses 
363 86.6 198 86 765 81.2 
 Hearing ability without aids 412 98.1 222 97 907 96.2 
        
Functional status       
 500 m walking ability without 
aids 
406 97.1 228 99.6 930 98.7 
 Going up and down the stairs 
without anyone’s help 
411 98.3 225 98.3 941 99.9 
 Doing any kind of exercise 405 98.8 224 99.6 931 99.3 
        
Table 27 Chair Stand Test 
     
  GO  SGO  RASIG 
     
  N  % N  % N  % 
        
Chair Stand Test       
 Able to perform 408 97.2 229 99.2 918 97 
 Stop after 1-4 times 1 0.2 1 0.4 3 0.3 
 Not able at all 11 2.6 1 0.4 25 2.7 
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Only the volunteers able to complete the test were considered for the analysis and it was 
carried out on the number of seconds spent to complete 5 chair stands. 
 
The average time spent by groups to perform the exercise was 10 seconds with the exception 
of RASIG males that used only 9.4 seconds (Table 28). 
 
 
As expected ages significantly affected the test performance of test and also gender played an 
important role (Table 29). RASIG subjects had the best performance (significant values). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 28 Chair Stand Test results divided for groups and gender  
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 173 10.416185 2.867252 5 8 10 12 23 
 F 235 10.536170 2.621772 5 9 10 12 25 
          
SGO M 133 10.624060 3.401429 5 8 10 12 25 
 F 96 10.645833 2.722148 6 9 10 12 23 
          
RASIG M 456 9.405702 2.948624 4 8 9 11 28 
 F 462 10.253247 3.589382 4 8 10 11 54 
          
Table 29 Chair Stand test and age linear regression corrected for group and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      5.463971 1.18e-07 3.442093 7.485849 
Subject_Group[T.RASIG] -0.799706 1.9e-07 -1.100597 -0.498814 
Subject_Group[T.SGO] 0.200594 0.346 -0.216457 0.617644 
Gender[T.M]   -0.543651 3.22e-05 -0.799957 -0.287345 
Age 0.076368 8.65e-07 0.045947 0.106790 
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Fig. 24 Chair Stand test and age linear regression 
 
 
4.2.6.2 Handgrip strength 
 
For this evaluation only volunteers able to complete the test were considered. The exercise 
consisted in three performances with each hand. The best performance of the dominant hand 
(strength expressed in kilograms) was used for the analysis (Gueresi et al., 2013).  
 
Males and females performed in a different way in accord with literature (Table 30). Males 
strength on average shifted between 40.9 Kg (RASIG) and 44.8 Kg (GO). Females strength 
on average ranged between 26.1 Kg (RASIG) and 27.5 Kg (GO).  
 
 
 
 
 
 
Table 30 Hand grip strength divided for groups and gender  
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 176 44.806818 9.951147 1 40 44.5 51 100 
 F 232 27.573276 5.606410 14 24 27.0 32 42 
          
SGO M 131 42.664122 8.353360 22 37 43 48 66 
 F 97 28.216495 5.381734 18 24 27 32 44 
          
RASIG M 461 40.965293 8.145343 0 35 41 46 62 
 F 475 26.143158 5.108582 10 23 26 30 44 
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Fig. 25 Violin plot of hand grip strength divide for groups and gender 
 
As happened before no particular difference was noted between GO and SGO subjects (both 
sexes) while a significant difference was found in RASIG volunteers ( in particular RASIG 
males) that also in this case had a significant worse performance (Table 31). As predicted, age 
had a significant impact on the test and particularly on RASIG volunteers (Fig.26). 
 
 
 
 
 
 
 
 
 
Fig. 26 Hand grip strength and age linear regression 
Table 31 hand grip strength and age linear regression 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      55.879941 7.83e-109 50.938233 60.821649 
Subject_Group[T.RASIG] -1.877921 7.34e-07 -2.621168 -1.134673 
Subject_Group[T.SGO] -0.779574 0.14 -1.814360 0.255211 
Gender[T.M]   15.616611 0 14.985046 16.248177 
Age -0.420594 1.2e-28 -0.494833 -0.346356 
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4.2.7 Anthropometric measurements 
 
In all recruited volunteers total height, knee height and the weight were measured. The data 
regarding knee height are not reported in this dissertation. 
 
Concerning total height, results indicate, as expected, that males were taller than females and 
in particular GO males (Table 32). Males total height ranged between 173.3 cm ± 6.7 (s.d.) 
(RASIG) and 175.1 cm ± 8 (GO). Females total height shifted between 160.8 cm ± 6.3 
(RASIG) and 162.9 cm ± 6.9 (SGO). In both sexes RASIG subjects were the smallest. 
 
Weight, as for height, was higher in males than females. Males values were comprised 
between 81.4 Kg ± 11.6 (RASIG) and 85.2 Kg ± 13.4 (SGO) while females weight ranged 
between 68.8 Kg ± 12.2 (GO) and 71.7 Kg ± 12 (SGO). 
 
 
BMI (Body Mass Index) calculated on weight and height data (K/m
2
) showed no particular 
differences between groups and gender and ranging between 26 ± 4.5 DS (GO females) and 
27.5 ± 3.8 DS (GO males). 
 
4.2.8 Cognitive Status 
 
4.2.8.1 Mini-Mental State Examination (SMMSE) 
 
SMMSE (Molloy et al., 1991) is the most commonly used instrument for screening cognitive 
function and can be used to indicate the presence of cognitive impairment. 
The entire sample obtained very high comparable scores (in all three groups) and also in both 
sexes (Table 33). Males scored between 28.4 (SGO) and 28.8 (GO) and females between 28.7 
Table 32 Anthropometric measurements 
    
  MALES FEMALES 
     
  GO 
Mean ± DS 
SGO 
Mean ± DS 
RASIG 
Mean ± DS 
GO 
Mean ± DS 
SGO 
Mean ± DS 
RASIG 
Mean ± DS 
        
 Height 175.1 ± 8 175.7 ± 7.2 173.3 ± 6.7  162,7 ± 6.2 162.9 ± 6.9 160.8 ± 6.3 
 Weight 84.3 ± 12.8 85.2 ± 13.4 81.4 ± 11.6  68.8 ± 12.2 71.7 ± 12 70.1 ± 13.4 
 BMI 27.5 ± 3.8 27.6 ± 4 27.1 ± 3.5 26 ± 4.5 27.1 ± 4.9 27.2 ± 5.1 
        
75 
(RASIG) and 29 (SGO). Analysing data for groups and gender no significant differences were 
found (Table 33) 
 
 
All the participants were divided in three categories (Nybo et al., 2003) on the base of the 
obtained score: 
 
1. “not impaired” (24–30 points) 
2. “mild impaired” (18–23 points) 
3. “severely impaired” (0–17 points) 
 
As expected almost the entire sample was classified as “not impaired” along with a very, very 
scarce percentage of subjects classified “mild impaired” (0.2% of GO and 1.1% of RASIG) 
(Table 34). No severely impaired volunteers were found. 
 
 
 
Table 33 Mini-Mental State Examination (SMMSE) divided for groups and gender 
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 177 28.887006 1.405630 23 28 29 30 30 
 F 241 28.937759 1.338635 24 28 29 30 30 
          
SGO M 133 28.458647 1.621406 24 27 29 30 30 
 F 97 29.020619 1.224569 24 29 29 30 30 
          
RASIG M 452 28.761062 1.415933 23 28 29 30 30 
 F 464 28.709052 1.656013 20 28 29 30 30 
          
Table 34 Mini-Mental State Examination (SMMSE) classification 
     
  GO  SGO  RASIG 
     
  N  % N  % N  % 
        
 Not impaired (24-30) 417 99.8 230 100 906 98.9 
 Mild Impaired (18-23) 1 0.2 0 0 10 1.1 
 Severely impaired (0-17) 0 0 0 0 0 0 
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As previously done, SMMSE test correlation with age was evaluated. No significant values 
were found. 
 
 
 
 
 
 
 
 
 
4.2.8.2 15 Picture Learning Test (15-PLT) 
 
15 Picture Learning Test (Brand and Jolles, 1985) is used to assess the immediate and delayed 
memory function. The test consists in three consecutive and repeated trials and a postponed 
recall after 20 minutes. The sum of the number of correct remembered pictures in the first 
three trials and the number of correct remembered pictures after the pause were used for the 
analysis. Low scores indicate a cognitive decline. Only the participants able to complete the 
test were evaluated. 
 
Sum of the three trials 
 
The three groups scored similarly without particular differences. The number of remembered 
figures shifted between 29 (GO) and 32.3 (SGO) (Table 36).  
Table 35 SMMSE and age linear regression corrected for groups and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      31.087456 0 29.895043 32.279870 
Subject_Group[T.RASIG] -0.087274 0.282 -0.246116 0.071568 
Subject_Group[T.SGO] -0.158043 0.165 -0.381391 0.065306 
Gender[T.M]   -0.039296 0.57 -0.174927 0.096334 
Age -0.023062 0.00812 -0.040138 -0.005986 
     
Table 36 15-PLT (sum of 3 trials) divided for groups and gender 
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 177 29.084746 5.962825 10 25 30 34 42 
 F 237 32.021097 4.734875 18 29 32 36 43 
          
SGO M 131 29.083969 5.240432 14 26 30 32.5 41 
 F 96 32.354167 4.462662 22 29 33 36 41 
          
RASIG M 453 30.048565 5.252671 11 27 30 34 43 
 F 464 31.342672 5.698417 12 28 32 35 43 
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Considering the “gender” variable, females showed to be significantly more efficient in the 
performance obtaining higher scores in all three groups (Table 37) 
 
As occurred previously, age impacted significantly on the execution of the test without 
significant differences in the three groups (Table 37) (Fig. 27) 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27 15-PLT (sum 3 thrials) and age linear regression 
 
Recall after 20 minutes 
 
As intended by test execution protocol participants were required to recall the figures 
previously seen in the three trials.  
 
Examined data showed that, as happened for the three trials, no particular differences were 
found in the three groups whose scores were comparable (Table 38) 
 
Table 37 15-PLT (sum 3 thrials) and age linear regression corrected for groups and gender  
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      48.933423 1.08e-115 44.738540 53.128307 
Subject_Group[T.RASIG] 0.382581   0.23 -0.242001 1.007163 
Subject_Group[T.SGO] -0.125344 0.778 -0.995854 0.745165 
Gender[T.M]   -2.044050 6.5e-14 -2.578384   -1.509716 
Age -0.259449 7.09e-16 -0.322470 -0.196428 
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Also in this case a “gender effect” was noticed. In fact in the recall trial females had a better 
and significant performance too (Table39). 
 
 
 
 
 
 
 
 
 
 
Even in this case age impacted significantly on the execution of the test (Table 39) (Fig. 28) 
 
 
Fig. 28 15 Picture Learning Test recall and age linear regression 
Table 38 15-PLT recall divided for groups and gender divided for groups and gender 
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 177 11.039548 2.691235 2 9 11 13 15 
 F 237 12.101266 2.100817 4 11 12 14 15 
          
SGO M 131 11.030534 2.252994 5 10 11 13 15 
 F 96 12.322917 2.013088 5 11 13 14 15 
          
RASIG M 453 11.379691 2.332292 4 10 12 13 15 
 F 464 11.976293 2.394531 0 10 12 14 15 
          
 
Table 39 15-PLT (recall) and age 15-PLT (sum 3 thrials) and age linear regression corrected 
for groups and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      18.864608 1.1e-95 17.083182 20.646035 
Subject_Group[T.RASIG] 0.166438 0.219    -0.098801 0.431677 
Subject_Group[T.SGO] -0.042211 0.823 -0.411887 0.327465 
Gender[T.M]   -0.825554 9.98e-13 -1.052468 -0.598641 
Age -0.101619 9.92e-14 -0.128382 -0.074856 
     
79 
4.2.8.3 Stroop Colour Word Test 
 
Stroop Test is used to test selective attention. The test consists in three sheets showing 40 
stimuli each, which the subject was asked to read or name as quickly as possible. The number 
of seconds spent performing the tasks were considered for the analysis. Lower is the number 
of seconds used the better the performance. 
 
Stroop Test Card 1 - Colour names 
 
The time used to complete the first trial ranged between 19.5 seconds (RASIG) and 21.7 
seconds (SGO) (Table 40). No particular variation between GO and SGO groups was noted 
on the contrary RASIG volunteers had the best significant performance (Table 41) 
 
Confirming expectations age showed to have an influence on the test performance (Fig. 29). 
 
 
 
 
 
 
 
 
 
 
Table 40 Stroop Test Card 1 divided for groups and gender divided for groups and gender 
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 177 21.463277 5.829008 13 18 20 24 63 
 F 241 21.219917 5.243784 12 17 21 24 42 
          
SGO M 134 21.798507 5.950649 12 18 20 24 42 
 F 97 20.886598 5.032967 12 18 20 23 44 
          
RASIG M 463 19.596112 7.144076 11 16 19 22 129 
 F 463 20.205184 5.379436 11 16 19 23 45 
          
Table 41 Stroop Test Card 1 and age linear regression corrected for groups and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      11.329390 1.69e-09 7.643657 15.015124 
Subject_Group[T.RASIG] -1.641430 4.12e-09   -2.188626 -1.094235 
Subject_Group[T.SGO] 0.075983 0.845 -0.685353 0.837319 
Gender[T.M]   -0.405243 0.0899 -0.873517 0.063032 
Age 0.145822 2.45e-07 0.090452 0.201191 
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Fig. 29 Stroop Test Card 1 and age linear regresssion 
 
Stroop Test Card 2 - Coloured patches 
 
The time used to complete the second trial ranged between 26.6 seconds (SGO) and 28.7 
seconds (SGO) (Table 42). No particular difference between groups was noted since times 
were comparable. No gender effect was found (Table 43).  
 
The only significant noteworthy data was the influence of age (Table 43). 
 
 
 
 
 
 
 
 
Table 42 Stroop Test Card 2 divided for groups and gender divided for groups and gender 
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 178 27.831461 7.976287 17 23 26 30 80 
 F 240 27.041667 6.914173 17 22 25 30 36 
          
SGO M 134 28.776119 8.251354 17 23 27 32 63 
 F 97 26.649485 6.245067 17 23 26 29 57 
          
RASIG M 464 26.711207 7.327174 15 22 25 30 54 
 F 471 26.651805 6.955007 15 22 25 30 57 
          
Table 43 Stroop Test Card 2 and age linear regression corrected for groups and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      9.732499 3.24e-05 5.142313 14.322685 
Subject_Group[T.RASIG] -0.759481 0.0293 -1.442572 -0.076391 
Subject_Group[T.SGO] 0.585165 0.228 -0.366586 1.536916 
Gender[T.M]   0.195266 0.512 -0.388357 0.778888 
Age 0.250099   1.15e-12 0.181164    0.319034 
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Fig. 30 Stroop Test Card 2and age linear regression 
 
Stroop Test Card 3 - Colour names printed in incongruously coloured ink.  
 
As expected, increasing the test difficulty the number of seconds spent in order to complete 
the trial increased. The times used ranged between 52.5 seconds (SGO) and 59.6 seconds 
(SGO) (Table 44).  
 
 
 
No particular trends were noted and no significant differences between groups and gender 
were found (Table 45) 
 
Evaluating data obtained, age seemed to be the only significant relation (Table 45) (Fig. 31)  
 
 
 
Table 44 Stroop Test Card 3 divided for groups and gender divided for groups and gender 
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 178 54.151685 22.659467 25 39 48 60 180 
 F 239 53.263598 20.750052 26 40 48 60 137 
          
SGO M 133 59.669173 24.840315 21 43 52 69 170 
 F 97 52.515464 18.720596 25 39 50 59 120 
          
RASIG M 463 53.224622 18.588308 25 41 48 60 173 
 F 469 55.375267 20.252991 20 42 50 63 154 
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Fig. 31 Stroop Test Card 3and age linear regression 
 
4.2.8.4 Digit Symbol Substitution Task (DSST) 
 
The processing speed of volunteers was assessed with the Digit-Symbol Substitution Task 
(Lezak et al., 2004). The number of correct digit-symbol combinations within 90 seconds was 
used for analysis.  
 
Table 45 Stroop Test Card 3 and age linear regression corrected for groups 
and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      -0.952290   0.876 -12.906707 11.002127 
Subject_Group[T.RASIG] 0.893595 0.325 -0.885542 2.672731 
Subject_Group[T.SGO] 2.804334 0.0267 0.324574 5.284094 
Gender[T.M]   -0.367248 0.636 -1.887580 1.153084 
Age 0.773399 3.15e-17 0.593816 0.952982 
     
Table 46 Stroop Test Card 3 divided for groups and gender divided for groups and gender 
          
SUBJECT 
GROUP 
GENDER COUNT MEAN STD MIN 25% 50% 75% MAX 
          
GO M 176 42.803977 12.317812 13 35 42 51 77 
 F 233 44.592275 11.712480 12 37 44 52 75 
          
SGO M 129 40.565891 11.239645 12 33 40 48 71 
 F 95 42.957895 10.370443 18 36 42 50.5 69 
          
RASIG M 430 42.677907 11.557058 15 34 43 51 76 
 F 440 43.297727 11.557866 10 35 44 51 75 
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The number of symbols properly replaced lied between 40.5 (SGO) and 44.5 (GO) (Table 
46). Even though there were 4 points of difference between the lowest score and the highest 
no significant difference was noted between groups or gender depending (Table 47). The only 
element able to have significant influence was age (Table 47) (Fig. 32) 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32 Digit Symbol Substitution Task and age linear regression 
 
 
 
 
 
 
 
 
 
Table 47 Digit Symbol Substitution Task (DSST) and age linear regression corrected 
for groups and gender 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      91.467880   3.84e-84 82.243993 100.691767 
Subject_Group[T.RASIG] -0.041698 0.952 -1.400812 1.317416 
Subject_Group[T.SGO]   -2.330457 0.0154 -4.214940 -0.445974 
Gender[T.M]   -1.048071 0.0792 -2.218312 0.122170 
Age -0.717171   3.66e-24     -0.855789    -0.578553 
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4.3 BIOCHEMICAL PREDICTORS 
 
The main goal of MARK-AGE Project was to identify a set of ageing biomarkers able to 
measure the biological ageing (or Bioage) along with the ageing rate, discriminating the 
bioage from the chronological one. 
 
In order to achieve this ambitious target a long list of parameters were investigated (Table 2 
page 20): 
 
 “CLASSICAL” parameter, for which data from several smaller studies have been 
published 
 “NEW/SPECIALISED” parameters, based on recent preliminary data 
 “NOVEL” parameters, based on recent research on mechanistic aspects of ageing 
 
MARK-AGE project generated a tremendous amount of data from which bioinformatics 
extracted a robust set of biomarkers, biochemical and phenotypical regressors (not shown in 
this dissertation). In other words the data were analyzed in order to ﬁnd relevant biochemical 
and phenotypical signatures that allowed to evaluate the bioage of an individual, to be 
confronted with the anagraphical one. This dissertation would propose a first approach for a 
simple model of “bioage” 
 
First of all, the BEST BIOCHEMICAL REGRESSORS/PARAMETERS (Fig. 33) were 
ranked in Female and Male of GO-SGO-RASIG volunteers.  
Fig. 33 List of best biochemical regressors sorted by descending Spearman's rank correlation coefficient 
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The most age correlated parameter was ELOVL2- CpG9-17-pca in both genders. ELOVL2 is 
a fatty acid elongation enzyme and its methylation status show a high correlation with 
chronological age.  
 
Extremely remarkable is the methylation status of specific CpG of ELOVL2 promotor : 
CpG9-17; CpG19-24; CpG2-8 belonging to the same island and relevant for both males and 
females. 
 
Unlike ELOVL2 the other regressors tend to be more gender specific. In females, top-seven 
positions are mainly filled with N-glycans-specific molecules along with DHEA -
Dehydroepiandrosterone sulfate (more significant in males) while in men the methylation 
status of CpG islands ELOVL2 and FHL2, another gene with methylation status found to be 
strongly associated with chronological age (Garagnani et al., 2012) are the protagonist along 
with DHEA and Lycopene plasma level. 
 
With the identification of the best biochemical and phenotypical biomarkers, it was possible 
to calculate the “predicted age” by a linear model fitting the best correlations (lines red in 
figure 34 and 35) thus able to “detect” the “Bio-age”. Analyzing the graphical distribution of 
“Bio-age” in GO and RASIG volunteers (separating males from females) the discrepancy 
between the two groups was immediately evident. As a matter of fact GO subjects (both 
males and females) apparently seemed to be younger than RASIG, being most of the data 
shifted below the red line in the younger area. 
 
 
 
 
 
 
 
 
 
 
Fig. 34 GO and RASIG males “Bio-age” 
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Fig. 35 GO and RASIG females “Bio-age” 
 
 
4.4 HEALTH, FUNCTIONAL AND COGNITIVE STATUS 
CORRELATIONS 
 
The possible relationship between, biomarkers and health status of the elderly in analysis has 
been examined. 
 
4.4.1 ELOVL2 and FHL2 metilation status 
 
Relation between the number of pathologies and ELOVL2 and FHL2 metilation status: 
 
The possible correlation between the number of pathologies affecting volunteers and the 
metilation status of ELOVL2 and FHL2 was tested (Table 48 and 49). Unfortunately no 
significant correlation was found in both cases (Fig. 36-37). 
 
 
 
Table 48 Number of pathologies and ELOVL_2_CpG_9_17_pca logistic regression corrected for 
groups, gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      -2.154610 9.69e-10 -2.845270 -1.463951 
Subject_Group[T.RASIG] 0.603929 7.17e-09 0.399387 0.808471 
Subject_Group[T.SGO] -0.026493 0.86 -0.320978 0.267992 
Gender[T.M]   -0.632632 1.32e-17 -0.777784 -0.487479 
ELOVL_2_CpG_9_17_pca 0.313394 0.717 -1.383616 2.010403 
Age 0.077429 2.01e-53 0.067566 0.087292 
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Fig. 36 Number of pathologies and ELOVL2 metilation status logistic regression 
 
 
Fig.37 Number of pathologies and FHL2 metilation status logistic regression 
 
Relation between Chair Stand Test and ELOVL2 and FHL2 metilation status: 
Chair Stand Test is a simple measure of lower extremity strength and a great indicator of 
disability. It is frequently used for example to examine functional status (Hammaren & 
Lindberg 2005, Suzuki et al. 2001, Liikavainio et al. 2008), lower extremity muscle 
Table 49 Number of pathologies and FHL2_CpG_9_20_pca logistic regression corrected for groups, 
gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      -2.187363 2.16e-12   -2.797757 -1.576969 
Subject_Group[T.RASIG] 0.655841 6.94e-09   0.433922 0.877760 
Subject_Group[T.SGO] -0.037673 0.811 -0.346791 0.271445 
Gender[T.M]   -0.587358 1.51e-13 -0.743211 -0.431504 
FHL2_CpG_9_20_pca -0.681305 0.389 -2.232868 0.870259 
Age 0.084472 1.39e-77 0.075593 0.093352 
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force/strength (Newcomer et al. 1993, Brown et al. 1995, Hughes et al. 2004, Manini et al. 
2005, Bohannon et al. 2005), or to discriminate between fallers and non-fallers (Campbell et 
al. 1989) in elderly population.  
 
Analysis showed that no significant correlation was found in both cases (Table 50 and Table 
51) 
 
 
 
 
 
 
Table 50 Chair Stand Test and ELOVL_2_CpG_9_17_pca logistic regression corrected for 
groups, gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      5.520162   7.18e-06 3.109533 7.930791 
Subject_Group[T.RASIG] -0.936942 1.3e-08 -1.259904 -0.613979 
Subject_Group[T.SGO] 0.039848 0.863 -0.414104 0.493800 
Gender[T.M]   -0.520529 0.000202 -0.795009 -0.246049 
ELOVL_2_CpG_9_17_pca 2.196952 0.196 -1.134552 5.528455 
Age 0.059129 0.000868 0.024328 0.093930 
     
Table 51 Chair Stand Test and FHL2_CpG_9_20_pca logistic regression corrected for groups, 
gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      5.721174 4.8e-06 3.269295 8.173054 
Subject_Group[T.RASIG] -0.755719 2.56e-05 -1.107568 -0.403870 
Subject_Group[T.SGO] 0.437997 0.0764 -0.046549 0.922544 
Gender[T.M]   -0.508478 0.000922 -0.809252 -0.207704 
FHL2_CpG_9_20_pca 2.483022   0.0852    -0.344138 5.310182 
Age   0.057244    0.002 0.020930 0.093557 
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Relation between Handgrip strenght and ELOVL2 and FHL2 metilation status: 
 
Muscle strength is supposed to be a potential predictor of declining health in elderly. It was 
demonstrated that poor handgrip strength can predict not only ADL dependency but also co 
cognitive decline (Taekema et al. 2010). 
 
No significant correlation was found (Table 52-53) 
 
 
 
 
Table 52 Handgrip strength and ELOVL_2_CpG_9_17_pca logistic regression corrected for 
groups, gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      59.305658 6.83e-84 53.316001 65.295314 
Subject_Group[T.RASIG] -1.857790   7.32e-06 -2.669787 -1.045793 
Subject_Group[T.SGO] -0.395082 0.499 -1.539616 0.749452 
Gender[T.M]   15.528736 0 14.840862 16.216611 
ELOVL_2_CpG_9_17_pca -8.274281 0.0501 -16.551347 0.002784 
Age -0.404182 3.72e-20 -0.490328 -0.318035 
     
Table 53 Handgrip strength and FHL2_CpG_9_20_pca logistic regression corrected for groups, 
gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      55.888003 1.06e-70 49.726215 62.049790 
Subject_Group[T.RASIG] -2.229399 1.14e-06 -3.127400 -1.331398 
Subject_Group[T.SGO] -1.064279 0.093 -2.306217 0.177658 
Gender[T.M]   15.385560      0   14.621749 16.149371 
FHL2_CpG_9_20_pca 3.348769   0.361 -3.831453 10.528991 
Age -0.437974 6.05e-21 -0.529401 -0.346547 
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Correlations with cognitive status was also tested but even in this case no significant 
correlations were found 
 
4.4.2 N-Glycans 
 
Health status of MARK-AGE volunteers was correlated also with N-Glycans. Possible 
correlations with peak 1, peak 6 and the log of p1/p6 ratio of N-Glycans were tested. 
Unfortunately the performed analysis showed no significant correlations. 
 
4.4.3 Serum glucose level and serum glycosylated haemoglobin level 
 
The connection between diabetes and cognitive impairment has been established but the 
influence of glucose regulation on attentional functions, which are sensitive to aging, is still 
unclear.  For this reason the possible correlation between the cognitive tests analysed in this 
dissertation and serum glucose level along with serum glycosylated haemoglobin level was 
tested.  
 
Relation between SMMSE and glucose and Glycosylated haemoglobin serum level: 
 
No significant correlation was found (table 54 and Table 55) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 54 SMMSE and serum glucose level logistic regression corrected for groups, 
gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      94.380518 5.06e-77 84.422167 104.338868 
Subject_Group[T.RASIG] 0.064707 0.928 -1.348205 1.477619 
Subject_Group[T.SGO] -1.989162 0.0464 -3.946741 -0.031584 
Gender[T.M]   -0.998573   0.112 -2.231587   0.234440 
Serum glucose -0.458059 0.0577 -0.931070 0.014951 
Age -0.724109 2.27e-22 -0.869983 -0.578235 
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Relation between Stroop Colour Word Test and glucose and Glycosylated haemoglobin 
serum level: 
 
A very significant correlation was found between Stroop Colour Word Test Card 1 and serum 
glucose level (Table 56) 
 
 
 
 
 
 
 
 
 
 
 
 
No significant correlation was found with serum glycosylated haemoglobin level.  
 
Stroop Test Card 2 had showed no significant difference with glucose and glycosylated 
haemoglobin. 
 
Table 55 SMMSE and serum glycosylated haemoglobin level logistic relation corrected 
for groups, gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      98.320922 5.56e-70 87.423836 109.218008 
Subject_Group[T.RASIG] 0.373057 0.599 -1.017926 1.764039 
Subject_Group[T.SGO] -2.058795 0.0376 -3.999789   -0.117802 
Gender[T.M]   -1.122736 0.0681 -2.328892 0.083421 
Glycosylated haemoglobin -1.003662 0.0301 -1.910872 -0.096453 
Age -0.728885 2.24e-23 -0.872292 -0.585478 
     
Table 56 Stroop Test Card 1 and serum glucose level logistic regression corrected for 
groups, gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      13.648532 1.27e-11 9.698654 17.598409 
Subject_Group[T.RASIG] -1.544746 9.3e-08 -2.111731 -0.977761 
Subject_Group[T.SGO] 0.114048 0.777 -0.674186 0.902281 
Gender[T.M]   -0.202750   0.419 -0.694730 0.289231 
Serum glucose -0.385485 5.51e-05 -0.572835 -0.198136 
Age 0.141383 1.84e-06 0.083293 0.199474 
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Stroop Test Card 3 showed a significant correlation with serum glucose level (Table 57) 
 
 
 
 
 
 
 
 
 
 
 
 
No correlation was found with serum glycosylated haemoglobin level. 
 
No correlation between Digit Symbol Substitution Task (DSST) e 15 Picture Learning Test 
with glucose and glycosylated haemoglobin serum level was found. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 57 Stroop Test Card 3 and serum glucose level logistic relation corrected for 
groups, gender and age 
     
 coef pvalues [95\% Conf. Int.] 
     
Intercept      3.860489 0.568 -9.379903 17.100882 
Subject_Group[T.RASIG] 1.046222 0.282 -0.859303 2.951746 
Subject_Group[T.SGO] 2.417639 0.0743 -0.237641 5.072919 
Gender[T.M]   0.395860 0.639 -1.256190 2.047911 
Serum glucose -1.199925 0.000179 -1.827680 -0.572170 
Age 0.798456 9.36e-16 0.603688 0.993224 
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5. DISCUSSION 
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5.1 MARK-AGE RECRUITMENT  
 
The main goal of the Large-Scale Integrated Project MARK-AGE was to recruit a large group 
of probands from different European countries supposed to be characterized by different rates 
of ageing to identify a robust set of ageing biomarkers across a range of physiological 
systems. 
 
MARK-AGE recruitment has been successful: 2336 RASIG, 566 GO, 323 SGO, 53 Down-
Syndrome 59 Cockayne-Syndrome and 50 Werner-Syndrome patients were recruited. In order 
to confirm the biological measurement robustness, 100 donors selected from the whole study 
population has been re-sampled within 3-6. Moreover, a small longitudinal study was 
performed by re-testing about the 12% of volunteers after 3  years from the first recruitment  
 
The success of MARK-AGE Project lies not only in achieving the number of programmed 
volunteers but thanks to the strategy behind the recruitment we may be able to analyse age-
gender effects, identify early ageing biomarkers and investigate a wide range of 
environmental, geographical and cultural effects on population. In fact MARK-AGE 
recruitment design has been carefully thought and formulated keeping in mind three key 
points: gender, age and geography. 
 
a. GENDER: males and females volunteers were recruited close to 50% in each age 
class. According to literature mortality rate is characterized by a gender effect, as a 
matter of fact women live longer than men albeit affected by a higher frequency of 
disabilities and comorbidities (Oksuzyan et al., 2008). The explanation behind this 
apparent contradiction has not been clarified yet but recent findings on age-dependent 
methylation pattern of sexual chromosomes (Capri et al., 2013; Gentilini et al., 2012; 
2013) seemed to be different suggesting a possible role.  
 
b. AGE: MARK-AGE has focused its attention on a specific range of age 34 and 75 
years in order to detect early ageing biomarkers. This choice has been made taking 
into account that the human beings, during their lifetime, goes through many phases of 
life and the age range between 60 and 75 years appears to be a critical temporal 
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window (Rauser et al., 2006) and likely the most interesting to identify biomarkers 
able to discriminate successful and unsuccessful ageing. 
 
c. GEOGRAPHY: according to literature geographical or environmental factors could 
have an influence on several biological parameters such as methylation patterns 
(Pirazzini et al., 2012). The analysis carried out on volunteers recruited by 11 different 
European beneficiaries, distributed from North to South could help to better define 
possible geographical impact. 
 
As mentioned above MARK-AGE Project has been a success even though extremely 
challenging as well as the majority of population-based studies involving older adults. In fact 
recruiting volunteers from this age group is particularly demanding and require a long and 
accurate planning that begins long before the first contact with potential candidates (Bonk 
2010). The identification of sample size and power requirement, targeting of participants, 
creation of protocols, localization of facilities and so on require a careful analysis and a high 
level of organization that is able to ensure that the recruitment can proceed without 
interruptions or problems. And this is what happened with MARK-AGE Project. In fact the 
success of the study is partially due to the almost perfect organizational process that every 
recruitment centres has been able to set up. However, it is fair to add, that great part of 
MARK-AGE success is due to recruiters commitment as the difficulties to be overcome, 
sometimes unexpected, were many.  
 
It is important to emphasize that fundamental was the great enthusiasm of contacted 
volunteers (according to UNIBO experience). Volunteers showed great desire to be part of 
such ambitious project and this not for personal gain but with the intent to improve the health 
of future generations. 
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5.2 BIOCHEMICAL AGE PREDICTORS AND THE "BIOLOGICAL 
AGE" 
 
The strong correlation between the methylation status of in ELOVL2 and FHL2 CpG islands 
and age is surely one of the most important finding in MARK-AGE Project and it was a 
confirm of previously results (Garagnani et al., 2012). 
 
ELOVL2 (ELOVL fatty acid elongase 2 ) belongs to ELOVL gene family (elongation-of-
very-long-chain-fatty acids) that encode elongases (Jakobsson et al., 2006) and encodes for a 
transmembrane protein, mainly expressed in the liver and involved in the synthesis of ὠ3 and 
ὠ6 polyunsaturated fatty acids (PUFA) (Leonard et al., 2002, Garagnani et al., 2012). 
Polyunsaturated fatty acids (PUFA) play an important role in many physiological processes 
such as modulation of inflammation, energy production and maintenance of cellular 
membrane integrity and their high plasma concentrations have been shown to have beneficial 
effects on cardiovascular disease and mortality (Tanaka et al., 2009). 
 
FHL2 (four and a half LIM domains 2) gene is located on chromosome 2q12–q14 
(Johannessen et al., 2006) and belongs to the FHL family (Genini et al., 1997). It is expressed 
mainly in heart, a little lower in ovary, a marginally in brain, liver and lung (Tanahashi and 
Tabira, 2000, Fung Ng et al., 2011) and it is also known to be down-regulated in 
rhabdomyosarcoma LIM (DRAL) domain protein (Fung Ng et al., 2011) 
 
Garagnani et al. in 2012, studing on a cohort of 500 subjects of different ages, strongly and 
unequivocally correlated the methylation level of three regions, the CpG islands of ELOVL2, 
FHL2, and PENK genes (all located in the respective gene promoter) with age. 
 
For this reasons ELOVL2 and FHL2 genes, that showed the most significant results in 
Garagnani study, were chosen to be investigated in MARKAGE. N-Glycans (in particular 
peak 1, 2, 6 and log p1/6), along with ELOVL2 and FHL2, have been identified as one of the 
best biomarkers. Protein glycosylation is the enzymatic addition of oligosaccharides (also 
known as glycans) to proteins and represents one of the most frequently form of co-
translational modification of proteins (Apweiler et al., 1999). Unlike what normally happens 
to RNA and proteins, glycans are being synthesized without a genetic template that pre-
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determines their ﬁnal structure and they are the results of complex interaction between 
hundreds of diﬀerent genes (Pucic et al., 2010). N-Glycans action takes place on many fronts, 
in fact they are involved in the folding and conformational stability of many proteins, mediate 
host–pathogen interactions and aspects of innate immunity etc. (Vanhooren et al., 2009). 
Serum N-glycan profiling has been indicated to have a potential to predict prognosis in 
patients undergoing haemodialysis and serum N-glycans alterations has been associated also 
with renal cell carcinoma (Hatakeyama et al., 2013). According to latest studies N-glycans 
can be a predictive prognosis factor in ulcerative colitis (Miyahara et al., 2013).  
 
N-glycans association with age was proved for the first time in 2009 by Vanhooren et., al 
showing that two N-glycan structures (NGA2F and NA2F) present in human blood 
glycoproteins changed with ageing. The following year it was showed that the log of the ratio 
of two glycans (NGA2F and NA2F), called GlycoAgeTest, remained steady up to the age of 
40 years and thereafter gradually increased to reach its highest level in nonagenarians 
(Vanhooren et., 2010). Recent data suggested that the N-glycomic shift observed in aging 
could be related not only to inﬂammation but also to alteration of important metabolic 
pathways (Dall’Olio et al., 2013) 
 
With all these premises N-Glycans and particularly NGA2F and NA2F resulted to be one of 
the best age predictors.  
 
The identification of this novel ageing biomarkers open a brand new and wide range of 
knowledge and it can be stated that now we can have access to a new level of comprehension 
of ageing mechanisms.  
 
Using these biomarkers it has been possible to formulate a model able to discriminate 
between bio-age and chronological age and this can be considered a tremendous result. The 
main assumptions of MARK-AGE namely that exist different ageing rate and that Geha 
Offsprings are biologically younger than age-matched normal population was confirmed.  
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5.3 GO, SGO AND RASIG HEALTH, FUNCTIONAL AND COGNITIVE 
STATUS AND THEIR RELATION WITH AGEING BIOMARKERS 
 
The main goal of this dissertation was to outline the health status of MARK-AGE elderly 
volunteers and eventually identify the presence of different ageing trajectories between the 
three group of recruited volunteers presumed to be characterized by distinctive ageing rate 
(GO, SGO and RASIG).  
 
Before starting the discussion it is important to underline that the sample in analysis is surely 
a “selected sample” since probably the subjects with the worst health status are to be found 
among those who refused to participate to the project.  
 
The aging process is frequently characterized by the presence of multimorbidity, disability, 
and frailty (Christensen et al. 2009). Finding elderly individual who presents only one single 
disease impairing the functionality of a single apparatus is really a rare occurrence (Nobili et 
al. 2011, Marengoni et al. 2008, Abete 2004). In order to get an idea of the magnitude of the 
phenomenon is sufficient to say that the multimorbidity affects more than half of the elderly 
population (Marengoni et al. 2011). Furthermore the presence of multimorbidity increases 
with age and worsens the indices of the perceived quality of life. Our sample accurately 
reflects the world situation, in fact MARK-AGE volunteers are characterized by 
multimorbidity and it is noteworthy that more than one-fifth of the sample reported to have 
other pathologies in addition to those investigated by the project. Moreover regarding 
multimorbidity and previous morbidity, the collected data may be underestimated since the 
medical history was reported without the support of medical reports but only confirmed by the 
ongoing pharmacological therapy. 
 
The diseases with higher prevalence among MARK-AGE participants were vision and 
hearing impairment, hypertension, hypercholesterolemia and arthritis that, as expected, 
affected mostly females. The percentages of subjects with vision deficits are extremely high. 
It is important to remember that the sensorial disabilities, such as impaired vision and hearing, 
may affect the perceived quality of life and elderly level of social integration as it jeopardizes 
their ability to communicate, leading to a limitation of normal social relationships. Moreover 
the vision and hearing impairment are important risk factors for falls and fractures and affect 
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the ability of the elderly to perform normal activities of daily living, which ultimately leads to 
growing needs of social and health care.  
 
Extremely diffused is the use of medications with remarkable percentages in all three 
recruited groups. Multiple medication use (prescription or OTC) is a common concern in 
relation to seniors’ health since elderly people are prone to drug-related problems such as 
inappropriate prescribing, adverse drug reactions, non-compliance with prescribed 
medications etc. (Elmståhl and Linder 2013) 
 
As reported in literature, females volunteers showed to have a worst health status. 
 
The sample in analysis showed no disability and this could be due to the phenomenon of self-
selection we mentioned before. However a significant presence of incontinence was found in 
women, as reported in literature. In fact urinary incontinence is a common geriatric syndrome 
that affects at least 1 in 3 older women (Goode et al., 2010). Incontinence problems have been 
found to be associated with higher incidence of many other health problems such as obesity 
and diabetes but this occurrence has not been evaluated in this dissertation. 
 
The assessment of functional performance was carried out with Chair Stand Test and 
measurement of handgrip strength and both showed deterioration with age, as reported in 
literature. 
 
Regarding cognitive status no subject showed cognitive impairment in MMSE evaluation but 
probably, as previously said, the more compromised individuals refused to participate. 
Mnemonic properties along with responsiveness to various stimuli tend to slowdown with age 
in an almost physiological phenomenon. All the performed cognitive test showed a worsening 
of scores as age increases. In 15 Pictures Learning Test females performed better than males 
but no reference of this was found in literature. Particularly interesting was the relation found 
between the execution of Stroop Test Card 1 and 3 and serum glucose level. Even though 
diabetes has been associated with cognitive decline and dementia, the relationship between 
the degree of hyperglycemia and cognitive status still remains unclear (Cukierman-Yaffe T, et 
al., 2009). Although data in the literature on this subject are still few, it has been suggested 
that glucose regulation may transiently influence performances of metabolically healthy older 
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adults on tasks requiring switching attention (Gagnon et al., 2011). Surely this point is 
definitely worth to be further investigated.  
Analysing the obtained data, two aspects are immediately evident: 
 
1. No significant difference between GO and SGO volunteers was found. 
 
2. RASIG volunteers showed to have an objectively worst health status confirming the 
initial hypothesis according to which individuals can have different ageing trajectories 
and that chronological age and biological age are not specular. 
 
Regarding the absence of differences between GO and SGO it is necessary to say that this 
may be due, at least in part, to the fact that the number of recruited SGO was much lower than 
the planned and this may have contributed to flatten the possible differences between the two 
groups.  
 
Concerning RASIG health status, as anticipated, all data indicates that RASIG volunteers are 
characterized by a worse health status. Proof of this is the fact that RASIG are affected by a 
significantly higher number of pathologies and use a significant higher number of 
medications. They showed a higher prevalence of vision impairment and previous myocardial 
infarction and tend to be more affected by cardiovascular diseases. Considering all the risk 
factors that can negatively influence the evolution of cardiovascular disease such as 
hypertension, diabetes and hypercholesterolemia, RASIG volunteers tend to be more 
metabolically unbalanced. Considering the functional status and in particular handgrip 
strength measurement they showed to perform significantly worse than GO and SGO while in 
Chair Stand Test they obtained the best results. No significant differences were found in 
cognition. 
 
We can therefore conclude that considering all these aspects, GO and SGO volunteers 
definitely have a better health status than RASIG. 
 
One goal of this dissertation was to explore possible relations between health status and some 
of the best biochemical regressors, in particular the metilation status of ELOVL2 and FHL2 
CpG island along with N-Glycans. Contrary to all expectations no significant correlations was 
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found. At the moment we are not able yet to explain the reason for this “negative” result. 
Considering the huge amount of data generated by MARK-AGE project it is possible that the 
real motivation lies in the fact that the most appropriate variables were not selected and the 
number of parameters with which we can investigate possible supplementary correlations are 
still many. Without doubt this event further stimulates our inquisitiveness and in a sense 
encourages us to think “outside the box” in order to find answers. 
 
5.4 CONCLUSIONS AND POSSIBLE FUTURE DEVELOPMENTS 
 
The results achieved by MARK-AGE Project have been absolutely remarkable and we think 
that this is the beginning. In this moment only small portions of knowledge has been revealed 
and definitely further analysis allow us to achieve a large part, if not all of the MARK-AGE 
prefixed goals. We hope that identification of ageing biomarkers along with Bio-age can be 
effective in the detection of individuals at high risk of developing age-associated diseases or 
disabilities and therefore a useful prevention tool in order to program prophylactic 
interventions or early-stage treatments of age-related diseases.  
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